{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 277281, "items": [{"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T11:46:03Z", "timestamp": 1574163963024}, "reference-count": 82, "publisher": "SAGE Publications", "issue": "9", "license": [{"URL": "http://journals.sagepub.com/page/policies/text-and-data-mining-license", "start": {"date-parts": [[2000, 9, 1]], "date-time": "2000-09-01T00:00:00Z", "timestamp": 967766400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Ann Pharmacother"], "published-print": {"date-parts": [[2000, 9]]}, "DOI": "10.1345/aph.19237", "type": "journal-article", "created": {"date-parts": [[2003, 6, 3]], "date-time": "2003-06-03T20:38:27Z", "timestamp": 1054672707000}, "page": "1032-1043", "source": "Crossref", "is-referenced-by-count": 102, "title": ["Voriconazole: A New Triazole Antifungal"], "prefix": "10.1177", "volume": "34", "author": [{"given": "Janelle A", "family": "Sabo", "sequence": "first", "affiliation": [{"name": "Janelle A Sabo PharmD, Visiting Scientist, Eli Lilly &amp; Co., Indianapolis, IN"}]}, {"given": "Susan M", "family": "Abdel-Rahman", "sequence": "additional", "affiliation": [{"name": "Susan M Abdel-Rahman PharmD, Assistant Professor of Pharmacy and Pediatrics, University of Missouri-Kansas City and the Children's Mercy Hospital, Kansas City, MO"}]}], "member": "179", "published-online": {"date-parts": [[2016, 6, 28]]}, "reference": [{"key": "bibr1-aph.19237", "DOI": "10.1016/S0190-9622(08)81495-8", "doi-asserted-by": "publisher"}, {"key": "bibr2-aph.19237", "DOI": "10.1016/0190-9622(90)70286-Q", "doi-asserted-by": "publisher"}, {"key": "bibr3-aph.19237", "author": "Fromtling R", "volume": "9", "first-page": "309", "year": "1996", "journal-title": "Drug News Perspect"}, {"key": "bibr4-aph.19237", "DOI": "10.1016/S0272-6386(98)70046-0", "doi-asserted-by": "publisher"}, {"key": "bibr5-aph.19237", "DOI": "10.1016/S0195-6701(98)90323-1", "doi-asserted-by": "publisher"}, {"key": "bibr6-aph.19237", "author": "Yamamura D", "volume": "160", "first-page": "493", "year": "1999", "journal-title": "Can Med Assoc J"}, {"key": "bibr7-aph.19237", "DOI": "10.2165/00003495-199753040-00001", "doi-asserted-by": "publisher"}, {"key": "bibr8-aph.19237", "DOI": "10.2165/00003088-199324010-00002", "doi-asserted-by": "publisher"}, {"key": "bibr9-aph.19237", "DOI": "10.2165/00003088-199325040-00006", "doi-asserted-by": "publisher"}, {"issue": "7", "key": "bibr10-aph.19237", "first-page": "58", "volume": "25", "author": "Graybill J", "year": "1998", "journal-title": "Semin Oncol"}, {"key": "bibr11-aph.19237", "author": "Fromtling R", "volume": "10", "first-page": "170", "year": "1997", "journal-title": "Drug News Perspect"}, {"key": "bibr13-aph.19237", "author": "Sanati H", "volume": "41", "first-page": "2492", "year": "1997", "journal-title": "Antimicrob Agents Chemother", "DOI": "10.1128/AAC.41.11.2492", "doi-asserted-by": "crossref"}, {"key": "bibr14-aph.19237", "author": "McGinnis M", "volume": "41", "first-page": "1832", "year": "1997", "journal-title": "Antimicrob Agents Chemother", "DOI": "10.1128/AAC.41.8.1832", "doi-asserted-by": "crossref"}, {"key": "bibr15-aph.19237", "author": "Barry AL", "volume": "40", "first-page": "1948", "year": "1996", "journal-title": "Antimicrob Agents Chemother", "DOI": "10.1128/AAC.40.8.1948", "doi-asserted-by": "crossref"}, {"key": "bibr16-aph.19237", "author": "Belanger P", "volume": "41", "first-page": "1840", "year": "1997", "journal-title": "Antimicrob Agents Chemother", "DOI": "10.1128/AAC.41.8.1840", "doi-asserted-by": "crossref"}, {"key": "bibr17-aph.19237", "author": "Marco F", "volume": "42", "first-page": "161", "year": "1998", "journal-title": "Antimicrob Agents Chemother", "DOI": "10.1128/AAC.42.1.161", "doi-asserted-by": "crossref"}, {"key": "bibr18-aph.19237", "DOI": "10.1016/S0732-8893(98)00005-4", "doi-asserted-by": "publisher"}, {"key": "bibr19-aph.19237", "author": "Clancy C", "volume": "17", "first-page": "573", "year": "1998", "journal-title": "Eur J Clin Microbiol Infect Dis"}, {"key": "bibr21-aph.19237", "author": "Manavathu EK", "volume": "42", "first-page": "3018", "year": "1998", "journal-title": "Antimicrob Agents Chemother", "DOI": "10.1128/AAC.42.11.3018", "doi-asserted-by": "crossref"}, {"key": "bibr24-aph.19237", "author": "Girmenia D", "volume": "36", "first-page": "1436", "year": "1998", "journal-title": "J Clin Microbiol"}, {"key": "bibr25-aph.19237", "author": "Rex J", "volume": "24", "first-page": "235", "year": "1997", "journal-title": "Clin Infect Dis", "DOI": "10.1093/clinids/24.2.235", "doi-asserted-by": "crossref"}, {"key": "bibr26-aph.19237", "author": "Verweij P", "volume": "5", "first-page": "1606", "year": "1999", "journal-title": "J Clin Microbiol"}, {"key": "bibr27-aph.19237", "DOI": "10.1111/j.1365-4362.1993.tb02844.x", "doi-asserted-by": "publisher"}, {"key": "bibr28-aph.19237", "DOI": "10.1111/j.1365-4362.1993.tb02833.x", "doi-asserted-by": "publisher"}, {"key": "bibr29-aph.19237", "author": "National Committee for Clinical Laboratory Standards.", "year": "1997", "volume-title": "Reference method for broth dilution of antifungal susceptibility testing of yeasts: approved standard"}, {"key": "bibr30-aph.19237", "DOI": "10.2165/00003088-199120040-00004", "doi-asserted-by": "publisher"}, {"key": "bibr31-aph.19237", "DOI": "10.2165/00003088-199733010-00005", "doi-asserted-by": "publisher"}, {"key": "bibr32-aph.19237", "DOI": "10.2165/00003088-199835060-00004", "doi-asserted-by": "publisher"}, {"key": "bibr34-aph.19237", "author": "Hegener P", "volume": "12", "first-page": "2227", "year": "1998", "journal-title": "AIDS"}, {"key": "bibr36-aph.19237", "author": "Bailey E", "volume": "10", "first-page": "146", "year": "1990", "journal-title": "Pharmacotherapy"}, {"key": "bibr37-aph.19237", "DOI": "10.2165/00003495-198937030-00003", "doi-asserted-by": "publisher"}, {"key": "bibr38-aph.19237", "DOI": "10.1093/jac/24.3.275", "doi-asserted-by": "publisher"}, {"key": "bibr39-aph.19237", "DOI": "10.1007/BF00558308", "doi-asserted-by": "publisher"}, {"key": "bibr40-aph.19237", "author": "Barrone J", "volume": "18", "first-page": "295", "year": "1998", "journal-title": "Pharmacotherapy"}, {"key": "bibr41-aph.19237", "DOI": "10.1128/AAC.32.9.1310", "doi-asserted-by": "publisher"}, {"key": "bibr42-aph.19237", "author": "Shibutani J", "volume": "44", "first-page": "53", "year": "1999", "journal-title": "J Antimicrob Chemother"}, {"key": "bibr43-aph.19237", "author": "Klepser ME", "volume": "41", "first-page": "1392", "year": "1997", "journal-title": "Antimicrob Agents Chemother", "DOI": "10.1128/AAC.41.6.1392", "doi-asserted-by": "crossref"}, {"key": "bibr44-aph.19237", "author": "Louie A", "volume": "42", "first-page": "1105", "year": "1998", "journal-title": "Antimicrob Agents Chemother", "DOI": "10.1128/AAC.42.5.1105", "doi-asserted-by": "crossref"}, {"key": "bibr48-aph.19237", "DOI": "10.1128/AAC.36.10.2239", "doi-asserted-by": "publisher"}, {"key": "bibr49-aph.19237", "DOI": "10.1111/j.1439-0507.1988.tb04433.x", "doi-asserted-by": "publisher"}, {"key": "bibr50-aph.19237", "DOI": "10.1007/BF02013902", "doi-asserted-by": "publisher"}, {"key": "bibr51-aph.19237", "DOI": "10.1179/joc.1998.10.1.7", "doi-asserted-by": "publisher"}, {"key": "bibr52-aph.19237", "DOI": "10.1086/513857", "doi-asserted-by": "publisher"}, {"key": "bibr53-aph.19237", "DOI": "10.2165/00003495-199754050-00004", "doi-asserted-by": "publisher"}, {"key": "bibr54-aph.19237", "author": "Armitage J", "volume": "92", "first-page": "4491", "year": "1998", "journal-title": "Blood"}, {"key": "bibr55-aph.19237", "author": "Vora S", "volume": "42", "first-page": "907", "year": "1998", "journal-title": "Antimicrob Agents Chemother", "DOI": "10.1128/AAC.42.4.907", "doi-asserted-by": "crossref"}, {"key": "bibr56-aph.19237", "DOI": "10.1093/jac/42.4.531", "doi-asserted-by": "publisher"}, {"key": "bibr58-aph.19237", "author": "Vora S", "volume": "42", "first-page": "2299", "year": "1998", "journal-title": "Antimicrob Agents Chemother", "DOI": "10.1128/AAC.42.9.2299", "doi-asserted-by": "crossref"}, {"key": "bibr59-aph.19237", "author": "Espinel-Ingroff A", "volume": "36", "first-page": "198", "year": "1998", "journal-title": "J Clin Microbiol"}, {"key": "bibr61-aph.19237", "author": "Radford S", "volume": "41", "first-page": "841", "year": "1997", "journal-title": "Antimicrob Agents Chemother", "DOI": "10.1128/AAC.41.4.841", "doi-asserted-by": "crossref"}, {"key": "bibr62-aph.19237", "DOI": "10.1080/02681219880000341", "doi-asserted-by": "publisher"}, {"key": "bibr63-aph.19237", "author": "Nguyen M", "volume": "42", "first-page": "471", "year": "1998", "journal-title": "Antimicrob Agents Chemother"}, {"key": "bibr65-aph.19237", "DOI": "10.1358/dof.1996.021.03.343618", "doi-asserted-by": "publisher"}, {"key": "bibr66-aph.19237", "DOI": "10.1046/j.1365-2141.1997.972911.x", "doi-asserted-by": "publisher"}, {"key": "bibr67-aph.19237", "DOI": "10.1086/515015", "doi-asserted-by": "publisher"}, {"key": "bibr68-aph.19237", "DOI": "10.1164/ajrccm.157.5.9709068", "doi-asserted-by": "publisher"}, {"key": "bibr69-aph.19237", "DOI": "10.1016/S1367-5931(97)80007-5", "doi-asserted-by": "publisher"}, {"key": "bibr70-aph.19237", "DOI": "10.1001/jama.1997.03540250013006", "doi-asserted-by": "publisher"}, {"key": "bibr72-aph.19237", "DOI": "10.1093/infdis/147.6.1060", "doi-asserted-by": "publisher"}, {"issue": "3", "key": "bibr73-aph.19237", "first-page": "S364", "volume": "12", "author": "Hay R", "year": "1990", "journal-title": "Rev Infect Dis"}, {"key": "bibr74-aph.19237", "DOI": "10.1016/S0002-9343(97)00307-0", "doi-asserted-by": "publisher"}, {"key": "bibr75-aph.19237", "DOI": "10.1080/02681218880000081", "doi-asserted-by": "publisher"}, {"key": "bibr76-aph.19237", "author": "Smith A", "volume": "112", "first-page": "92", "year": "1998", "journal-title": "J Laryngol Otol"}, {"key": "bibr77-aph.19237", "DOI": "10.1093/clinids/22.Supplement_2.S166", "doi-asserted-by": "publisher"}, {"key": "bibr80-aph.19237", "DOI": "10.1200/JCO.1997.15.1.139", "doi-asserted-by": "publisher"}, {"key": "bibr81-aph.19237", "DOI": "10.1086/517646", "doi-asserted-by": "publisher"}, {"key": "bibr82-aph.19237", "DOI": "10.1016/0002-9343(94)90023-X", "doi-asserted-by": "publisher"}, {"key": "bibr83-aph.19237", "DOI": "10.1111/j.1365-2141.1994.tb04825.x", "doi-asserted-by": "publisher"}, {"key": "bibr84-aph.19237", "author": "White M", "volume": "24", "first-page": "635", "year": "1997", "journal-title": "Clin Infect Dis"}, {"key": "bibr85-aph.19237", "DOI": "10.1001/archinte.1997.00440370097010", "doi-asserted-by": "publisher"}, {"key": "bibr86-aph.19237", "DOI": "10.1093/clinids/23.3.608", "doi-asserted-by": "publisher"}, {"key": "bibr87-aph.19237", "DOI": "10.1086/515033", "doi-asserted-by": "publisher"}, {"key": "bibr88-aph.19237", "author": "Kusuhara M", "volume": "36", "first-page": "684", "year": "1997", "journal-title": "Int J Dermatol", "DOI": "10.1046/j.1365-4362.1997.00287.x", "doi-asserted-by": "crossref"}, {"key": "bibr89-aph.19237", "DOI": "10.1093/clinids/23.1.192", "doi-asserted-by": "publisher"}, {"key": "bibr90-aph.19237", "author": "Dellestable F", "volume": "21", "first-page": "766", "year": "1994", "journal-title": "J Rheumatol"}, {"key": "bibr91-aph.19237", "DOI": "10.1097/00007611-199008000-00025", "doi-asserted-by": "publisher"}, {"key": "bibr92-aph.19237", "DOI": "10.1097/00005792-199707000-00004", "doi-asserted-by": "publisher"}, {"key": "bibr93-aph.19237", "DOI": "10.1111/j.1365-2141.1994.tb04897.x", "doi-asserted-by": "publisher"}, {"key": "bibr95-aph.19237", "DOI": "10.1128/AAC.39.8.1696", "doi-asserted-by": "publisher"}, {"key": "bibr96-aph.19237", "DOI": "10.1128/AAC.42.10.2645", "doi-asserted-by": "publisher"}, {"key": "bibr97-aph.19237", "DOI": "10.1128/AAC.37.9.1962", "doi-asserted-by": "publisher"}, {"key": "bibr98-aph.19237", "DOI": "10.1042/bst0211039", "doi-asserted-by": "publisher"}], "container-title": ["Annals of Pharmacotherapy"], "language": "en", "link": [{"URL": "http://journals.sagepub.com/doi/pdf/10.1345/aph.19237", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://journals.sagepub.com/doi/pdf/10.1345/aph.19237", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 2, 14]], "date-time": "2019-02-14T12:35:27Z", "timestamp": 1550147727000}, "score": 43.66031, "issued": {"date-parts": [[2000, 9]]}, "references-count": 82, "journal-issue": {"published-online": {"date-parts": [[2016, 6, 28]]}, "published-print": {"date-parts": [[2000, 9]]}, "issue": "9"}, "alternative-id": ["10.1345/aph.19237"], "URL": "http://dx.doi.org/10.1345/aph.19237", "relation": {"cites": []}, "ISSN": ["1060-0280", "1542-6270"], "issn-type": [{"value": "1060-0280", "type": "print"}, {"value": "1542-6270", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T20:07:54Z", "timestamp": 1574280474956}, "reference-count": 83, "publisher": "Springer Science and Business Media LLC", "issue": "1", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2009, 2, 14]], "date-time": "2009-02-14T00:00:00Z", "timestamp": 1234569600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Curr Fungal Infect Rep"], "published-print": {"date-parts": [[2009, 3]]}, "DOI": "10.1007/s12281-009-0005-y", "type": "journal-article", "created": {"date-parts": [[2009, 2, 13]], "date-time": "2009-02-13T05:21:50Z", "timestamp": 1234502510000}, "page": "32-39", "source": "Crossref", "is-referenced-by-count": 1, "title": ["The role of second-generation triazole antifungal agents voriconazole and posaconazole in patients with hematologic malignancies"], "prefix": "10.1007", "volume": "3", "author": [{"given": "Eric J.", "family": "Bow", "sequence": "first", "affiliation": []}, {"given": "D.", "family": "Bacteriol", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2009, 2, 14]]}, "reference": [{"key": "5_CR1", "doi-asserted-by": "crossref", "first-page": "296", "DOI": "10.1007/s15010-008-7357-z", "volume": "36", "author": "O.A. Cornely", "year": "2008", "unstructured": "Cornely OA: Aspergillus to zygomycetes: causes, risk factors, prevention, and treatment of invasive fungal infections. Infection 2008, 36:296\u2013313.", "journal-title": "Infection"}, {"key": "5_CR2", "doi-asserted-by": "crossref", "first-page": "133", "DOI": "10.1111/j.1365-2141.2007.06906.x", "volume": "140", "author": "E.J. Bow", "year": "2008", "unstructured": "Bow EJ: Considerations in the approach to invasive fungal infection in patients with haematological malignancies. Br J Haematol 2008, 140:133\u2013152.", "journal-title": "Br J Haematol"}, {"key": "5_CR3", "doi-asserted-by": "crossref", "first-page": "569", "DOI": "10.1097/00001432-200212000-00003", "volume": "15", "author": "T.A. Clark", "year": "2002", "unstructured": "Clark TA, Hajjeh RA: Recent trends in the epidemiology of invasive mycoses. Curr Opin Infect Dis 2002, 15:569\u2013574.", "journal-title": "Curr Opin Infect Dis"}, {"key": "5_CR4", "doi-asserted-by": "crossref", "first-page": "213", "DOI": "10.1016/S1130-1406(07)70045-1", "volume": "24", "author": "I. Jarque", "year": "2007", "unstructured": "Jarque I, Sanz MA: [Current indications for voriconazole in onco-hematological patients]. Rev Iberoam Micol 2007, 24:213\u2013216.", "journal-title": "Rev Iberoam Micol"}, {"key": "5_CR5", "first-page": "1068", "volume": "91", "author": "L. Pagano", "year": "2006", "unstructured": "Pagano L, Caira M, Candoni A, et al.: The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. Haematologica 2006, 91:1068\u20131075.", "journal-title": "Haematologica"}, {"key": "5_CR6", "doi-asserted-by": "crossref", "first-page": "641", "DOI": "10.1086/322606", "volume": "33", "author": "M.M. McNeil", "year": "2001", "unstructured": "McNeil MM, Nash SL, Hajjeh RA, et al.: Trends in mortality due to invasive mycotic diseases in the United States, 1980\u20131997. Clin Infect Dis 2001, 33:641\u2013647.", "journal-title": "Clin Infect Dis"}, {"key": "5_CR7", "doi-asserted-by": "crossref", "first-page": "1862", "DOI": "10.1016/j.clinthera.2007.09.015", "volume": "29", "author": "D.S. Schiller", "year": "2007", "unstructured": "Schiller DS, Fung HB: Posaconazole: an extended-spectrum triazole antifungal agent. Clin Ther 2007, 29:1862\u20131886.", "journal-title": "Clin Ther"}, {"key": "5_CR8", "doi-asserted-by": "crossref", "first-page": "269", "DOI": "10.2165/00003495-200767020-00009", "volume": "67", "author": "L.J. Scott", "year": "2007", "unstructured": "Scott LJ, Simpson D: Voriconazole: a review of its use in the management of invasive fungal infections. Drugs 2007, 67:269\u2013298.", "journal-title": "Drugs"}, {"key": "5_CR9", "doi-asserted-by": "crossref", "first-page": "2492", "DOI": "10.1128/AAC.41.11.2492", "volume": "41", "author": "H. Sanati", "year": "1997", "unstructured": "Sanati H, Belanger P, Fratti R, Ghannoum M: A new triazole, voriconazole (UK-109,496), blocks sterol biosynthesis in Candida albicans and Candida krusei. Antimicrob Agents Chemother 1997, 41:2492\u20132496.", "journal-title": "Antimicrob Agents Chemother"}, {"key": "5_CR10", "doi-asserted-by": "crossref", "first-page": "630", "DOI": "10.1086/367933", "volume": "36", "author": "L.B. Johnson", "year": "2003", "unstructured": "Johnson LB, Kauffman CA: Voriconazole: a new triazole antifungal agent. Clin Infect Dis 2003, 36:630\u2013637.", "journal-title": "Clin Infect Dis"}, {"key": "5_CR11", "doi-asserted-by": "crossref", "first-page": "2009", "DOI": "10.1128/AAC.00163-06", "volume": "50", "author": "F. Sabatelli", "year": "2006", "unstructured": "Sabatelli F, Patel R, Mann PA, et al.: In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts. Antimicrob Agents Chemother 2006, 50:2009\u20132015.", "journal-title": "Antimicrob Agents Chemother"}, {"key": "5_CR12", "doi-asserted-by": "crossref", "first-page": "917", "DOI": "10.1128/AAC.50.3.917-921.2006", "volume": "50", "author": "M. Cuenca-Estrella", "year": "2006", "unstructured": "Cuenca-Estrella M, Gomez-Lopez A, Mellado E, et al.: Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi. Antimicrob Agents Chemother 2006, 50:917\u2013921.", "journal-title": "Antimicrob Agents Chemother"}, {"issue": "Suppl1", "key": "5_CR13", "doi-asserted-by": "crossref", "first-page": "7", "DOI": "10.1111/j.1439-0507.2008.01523.x", "volume": "51", "author": "H.P. Lipp", "year": "2008", "unstructured": "Lipp HP: Antifungal agents-clinical pharmacokinetics and drug interactions. Mycoses 2008, 51(Suppl 1):7\u201318.", "journal-title": "Mycoses"}, {"key": "5_CR14", "doi-asserted-by": "crossref", "first-page": "1241", "DOI": "10.1086/424662", "volume": "39", "author": "A.E. Boyd", "year": "2004", "unstructured": "Boyd AE, Modi S, Howard SJ, et al.: Adverse reactions to voriconazole. Clin Infect Dis 2004, 39:1241\u20131244.", "journal-title": "Clin Infect Dis"}, {"key": "5_CR15", "doi-asserted-by": "crossref", "first-page": "451", "DOI": "10.1038/sj.bmt.1705754", "volume": "40", "author": "S. Trifilio", "year": "2007", "unstructured": "Trifilio S, Singhal S, Williams S, et al.: Breakthrough fungal infections after allogeneic hematopoietic stem cell transplantation in patients on prophylactic voriconazole. Bone Marrow Transplant 2007, 40:451\u2013456.", "journal-title": "Bone Marrow Transplant"}, {"key": "5_CR16", "doi-asserted-by": "crossref", "first-page": "1532", "DOI": "10.1002/cncr.22568", "volume": "109", "author": "S. Trifilio", "year": "2007", "unstructured": "Trifilio S, Pennick G, Pi J, et al.: Monitoring plasma voriconazole levels may be necessary to avoid subtherapeutic levels in hematopoietic stem cell transplant recipients. Cancer 2007, 109:1532\u20131535.", "journal-title": "Cancer"}, {"key": "5_CR17", "doi-asserted-by": "crossref", "first-page": "201", "DOI": "10.1086/524669", "volume": "46", "author": "A. Pascual", "year": "2008", "unstructured": "Pascual A, Calandra T, Bolay S, et al.: Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes. Clin Infect Dis 2008, 46:201\u2013211.", "journal-title": "Clin Infect Dis"}, {"key": "5_CR18", "doi-asserted-by": "crossref", "first-page": "1627", "DOI": "10.1592/phco.27.12.1627", "volume": "27", "author": "G. Krishna", "year": "2007", "unstructured": "Krishna G, Martinho M, Chandrasekar P, et al.: Pharmacokinetics of oral posaconazole in allogeneic hematopoietic stem cell transplant recipients with graft-versus-host disease. Pharmacotherapy 2007, 27:1627\u20131636.", "journal-title": "Pharmacotherapy"}, {"key": "5_CR19", "doi-asserted-by": "crossref", "first-page": "658", "DOI": "10.1128/AAC.50.2.658-666.2006", "volume": "50", "author": "A.J. Ullmann", "year": "2006", "unstructured": "Ullmann AJ, Cornely OA, Burchardt A, et al.: Pharmacokinetics, safety, and efficacy of posaconazole in patients with persistent febrile neutropenia or refractory invasive fungal infection. Antimicrob Agents Chemother 2006, 50:658\u2013666.", "journal-title": "Antimicrob Agents Chemother"}, {"key": "5_CR20", "doi-asserted-by": "crossref", "first-page": "521", "DOI": "10.1111/j.1445-5994.2008.01726.x", "volume": "38", "author": "L.J. Worth", "year": "2008", "unstructured": "Worth LJ, Blyth CC, Booth DL, et al.: Optimizing antifungal drug dosing and monitoring to avoid toxicity and improve outcomes in patients with haematological disorders. Intern Med J 2008, 38:521\u2013537.", "journal-title": "Intern Med J"}, {"key": "5_CR21", "doi-asserted-by": "crossref", "first-page": "580", "DOI": "10.1097/QCO.0b013e3283184611", "volume": "21", "author": "W.W. Hope", "year": "2008", "unstructured": "Hope WW, Billaud EM, Lestner J, Denning DW: Therapeutic drug monitoring for triazoles. Curr Opin Infect Dis 2008, 21:580\u2013586.", "journal-title": "Curr Opin Infect Dis"}, {"key": "5_CR22", "doi-asserted-by": "crossref", "first-page": "467", "DOI": "10.1586/14787210.3.4.467", "volume": "3", "author": "A.H. Groll", "year": "2005", "unstructured": "Groll AH, Walsh TJ: Posaconazole: clinical pharmacology and potential for management of fungal infections. Expert Rev Anti Infect Ther 2005, 3:467\u2013487.", "journal-title": "Expert Rev Anti Infect Ther"}, {"key": "5_CR23", "doi-asserted-by": "crossref", "first-page": "730", "DOI": "10.1086/339215", "volume": "34", "author": "W.T. Hughes", "year": "2002", "unstructured": "Hughes WT, Armstrong D, Bodey GP, et al.: 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 2002, 34:730\u2013751.", "journal-title": "Clin Infect Dis"}, {"key": "5_CR24", "first-page": "1", "volume": "49", "author": "Centers for Disease ControlPrevention", "year": "2000", "unstructured": "Centers for Disease Control and Prevention: Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. MMWR Recomm Rep 2000, 49:1\u20137.", "journal-title": "MMWR Recomm Rep"}, {"key": "5_CR25", "doi-asserted-by": "crossref", "first-page": "139", "DOI": "10.1086/321805", "volume": "33", "author": "C.A. Dykewicz", "year": "2001", "unstructured": "Dykewicz CA: Summary of the guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. Clin Infect Dis 2001, 33:139\u2013144.", "journal-title": "Clin Infect Dis"}, {"issue": "Suppl2", "key": "5_CR26", "doi-asserted-by": "crossref", "first-page": "S186", "DOI": "10.1007/s00277-003-0773-3", "volume": "82", "author": "O.A. Cornely", "year": "2003", "unstructured": "Cornely OA, Bohme A, Buchheidt D, et al.: Prophylaxis of invasive fungal infections in patients with hematological malignancies and solid tumors-guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol 2003, 82(Suppl 2):S186\u2013S200.", "journal-title": "Ann Hematol"}, {"issue": "Suppl2", "key": "5_CR27", "first-page": "S79", "volume": "22", "author": "M.E. Santolaya", "year": "2005", "unstructured": "Santolaya ME, Rabagliati R, Bidart T, et al.: [Consensus: Rational approach towards the patient with cancer, fever and neutropenia]. Rev Chilena Infectol 2005, 22(Suppl 2):S79\u2013S113.", "journal-title": "Rev Chilena Infectol"}, {"key": "5_CR28", "doi-asserted-by": "crossref", "first-page": "348", "DOI": "10.1056/NEJMoa061094", "volume": "356", "author": "O.A. Cornely", "year": "2007", "unstructured": "Cornely OA, Maertens J, Winston DJ, et al.: Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia. N Engl J Med 2007, 356:348\u2013359.", "journal-title": "N Engl J Med"}, {"key": "5_CR29", "doi-asserted-by": "crossref", "first-page": "445", "DOI": "10.1016/j.jinf.2007.07.003", "volume": "55", "author": "J.J. Vehreschild", "year": "2007", "unstructured": "Vehreschild JJ, Bohme A, Buchheidt D, et al.: A double-blind trial on prophylactic voriconazole (VRC) or placebo during induction chemotherapy for acute myelogenous leukaemia (AML). J Infect 2007, 55:445\u2013449.", "journal-title": "J Infect"}, {"key": "5_CR30", "doi-asserted-by": "crossref", "first-page": "43", "DOI": "10.1016/j.ejcsup.2007.06.006", "volume": "5", "author": "J.A. Maertens", "year": "2007", "unstructured": "Maertens JA, Frere P, Lass-Florl C, et al.: Primary antifungal prophylaxis in leukaemia patients. Eur J Cancer Suppl 2007, 5:43\u201348.", "journal-title": "Eur J Cancer Suppl"}, {"key": "5_CR31", "doi-asserted-by": "crossref", "first-page": "327", "DOI": "10.1086/525258", "volume": "46", "author": "T. Walsh", "year": "2008", "unstructured": "Walsh T, Anaissie E, Denning D, et al.: Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2008, 46:327\u2013360.", "journal-title": "Clin Infect Dis"}, {"key": "5_CR32", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1007/s11046-006-0025-x", "volume": "162", "author": "Z. Bhatti", "year": "2006", "unstructured": "Bhatti Z, Shaukat A, Almyroudis NG, Segal BH: Review of epidemiology, diagnosis, and treatment of invasive mould infections in allogeneic hematopoietic stem cell transplant recipients. Mycopathologia 2006, 162:1\u201315.", "journal-title": "Mycopathologia"}, {"key": "5_CR33", "doi-asserted-by": "crossref", "first-page": "293", "DOI": "10.1080/13693780701885552", "volume": "46", "author": "K.A. Marr", "year": "2008", "unstructured": "Marr KA: Fungal infections in hematopoietic stem cell transplant recipients. Med Mycol 2008, 46:293\u2013302.", "journal-title": "Med Mycol"}, {"key": "5_CR34", "doi-asserted-by": "crossref", "first-page": "181", "DOI": "10.1007/s11046-004-5495-0", "volume": "159", "author": "A. Shaukat", "year": "2005", "unstructured": "Shaukat A, Bakri F, Young P, et al.: Invasive filamentous fungal infections in allogeneic hematopoietic stem cell transplant recipients after recovery from neutropenia: clinical, radiologic, and pathologic characteristics. Mycopathologia 2005, 159:181\u2013188.", "journal-title": "Mycopathologia"}, {"key": "5_CR35", "unstructured": "Bow EJ: Invasive fungal infection in haematopoietic stem cell transplant recipients: epidemiology from the transplant physician\u2019s viewpoint. Mycopathologia 2008 (in press).", "DOI": "10.1007/s11046-009-9196-6", "doi-asserted-by": "crossref"}, {"key": "5_CR36", "first-page": "2055", "volume": "96", "author": "K.A. Marr", "year": "2000", "unstructured": "Marr KA, Seidel K, Slavin MA, et al.: Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: long-term follow-up of a randomized, placebo-controlled trial. Blood 2000, 96:2055\u20132061.", "journal-title": "Blood"}, {"key": "5_CR37", "doi-asserted-by": "crossref", "first-page": "309", "DOI": "10.1086/315193", "volume": "181", "author": "K.A. Marr", "year": "2000", "unstructured": "Marr KA, Seidel K, White TC, Bowden RA: Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption of prophylactic fluconazole. J Infect Dis 2000, 181:309\u2013316.", "journal-title": "J Infect Dis"}, {"key": "5_CR38", "doi-asserted-by": "crossref", "first-page": "359", "DOI": "10.1016/j.ijantimicag.2006.01.002", "volume": "27", "author": "A.M. Tortorano", "year": "2006", "unstructured": "Tortorano AM, Kibbler C, Peman J, et al.: Candidaemia in Europe: epidemiology and resistance. Int J Antimicrob Agents 2006, 27:359\u2013366.", "journal-title": "Int J Antimicrob Agents"}, {"key": "5_CR39", "doi-asserted-by": "crossref", "first-page": "2493", "DOI": "10.1002/cncr.23466", "volume": "112", "author": "R. Hachem", "year": "2008", "unstructured": "Hachem R, Hanna H, Kontoyiannis D, et al.: The changing epidemiology of invasive candidiasis: Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy. Cancer 2008, 112:2493\u20132499.", "journal-title": "Cancer"}, {"key": "5_CR40", "doi-asserted-by": "crossref", "first-page": "230", "DOI": "10.1016/S1473-3099(03)00580-2", "volume": "3", "author": "D.W. Denning", "year": "2003", "unstructured": "Denning DW, Kibbler CC, Barnes RA: British Society for Medical Mycology proposed standards of care for patients with invasive fungal infections. Lancet Infect Dis 2003, 3:230\u2013240.", "journal-title": "Lancet Infect Dis"}, {"key": "5_CR41", "doi-asserted-by": "crossref", "first-page": "309", "DOI": "10.1097/00006454-199005000-00002", "volume": "9", "author": "V.M. Dato", "year": "1990", "unstructured": "Dato VM, Dajani AS: Candidemia in children with central venous catheters: role of catheter removal and amphotericin B therapy. Pediatr Infect Dis J 1990, 9:309\u2013314.", "journal-title": "Pediatr Infect Dis J"}, {"key": "5_CR42", "doi-asserted-by": "crossref", "first-page": "99", "DOI": "10.1097/00006454-198909001-00001", "volume": "8", "author": "S.C. Eppes", "year": "1989", "unstructured": "Eppes SC, Troutman JL, Gutman LT: Outcome of treatment of candidemia in children whose central venous catheters were removed or retained. Pediatr Infect Dis 1989, 8:99\u2013104.", "journal-title": "Pediatr Infect Dis"}, {"key": "5_CR43", "doi-asserted-by": "crossref", "first-page": "994", "DOI": "10.1093/clinids/21.4.994", "volume": "21", "author": "J.H. Rex", "year": "1995", "unstructured": "Rex JH, Bennett JE, Sugar AM, et al.: Intravascular catheter exchanges and the duration of candidemia. Clin Infect Dis 1995, 21:994\u2013996.", "journal-title": "Clin Infect Dis"}, {"key": "5_CR44", "doi-asserted-by": "crossref", "first-page": "1435", "DOI": "10.1016/S0140-6736(05)67490-9", "volume": "366", "author": "B.J. Kullberg", "year": "2005", "unstructured": "Kullberg BJ, Sobel JD, Ruhnke M, et al.: Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial. Lancet 2005, 366:1435\u20131442.", "journal-title": "Lancet"}, {"key": "5_CR45", "doi-asserted-by": "crossref", "first-page": "97", "DOI": "10.1007/s00277-008-0622-5", "volume": "88", "author": "A. Bohme", "year": "2009", "unstructured": "Bohme A, Ruhnke M, Buchheidt D, et al.: Treatment of invasive fungal infections in cancer patients: recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol 2009, 88:97\u2013110.", "journal-title": "Ann Hematol"}, {"key": "5_CR46", "doi-asserted-by": "crossref", "first-page": "161", "DOI": "10.1086/380796", "volume": "38", "author": "P.G. Pappas", "year": "2004", "unstructured": "Pappas PG, Rex JH, Sobel JD, et al.: Guidelines for treatment of candidiasis. Clin Infect Dis 2004, 38:161\u2013189.", "journal-title": "Clin Infect Dis"}, {"key": "5_CR47", "doi-asserted-by": "crossref", "first-page": "49", "DOI": "10.1016/j.ejcsup.2007.06.007", "volume": "5", "author": "R. Herbrecht", "year": "2007", "unstructured": "Herbrecht R, Fluckiger U, Gachot B, et al.: Treatment of invasive Candida and invasive Aspergillus infections in adult haematological patients. Eur J Cancer Suppl 2007, 5:49\u201359.", "journal-title": "Eur J Cancer Suppl"}, {"key": "5_CR48", "doi-asserted-by": "crossref", "first-page": "408", "DOI": "10.1056/NEJMoa020191", "volume": "347", "author": "R. Herbrecht", "year": "2002", "unstructured": "Herbrecht R, Denning DW, Patterson TF, et al.: Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002, 347:408\u2013415.", "journal-title": "N Engl J Med"}, {"key": "5_CR49", "doi-asserted-by": "crossref", "first-page": "1289", "DOI": "10.1086/514341", "volume": "44", "author": "O.A. Cornely", "year": "2007", "unstructured": "Cornely OA, Maertens J, Bresnik M, et al.: Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial). Clin Infect Dis 2007, 44:1289\u20131297.", "journal-title": "Clin Infect Dis"}, {"key": "5_CR50", "doi-asserted-by": "crossref", "first-page": "1176", "DOI": "10.1086/592255", "volume": "47", "author": "Y. Nivoix", "year": "2008", "unstructured": "Nivoix Y, Velten M, Letscher-Bru V, et al.: Factors associated with overall and attributable mortality in invasive aspergillosis. Clin Infect Dis 2008, 47:1176\u20131184.", "journal-title": "Clin Infect Dis"}, {"key": "5_CR51", "doi-asserted-by": "crossref", "first-page": "373", "DOI": "10.1086/509917", "volume": "44", "author": "R.E. Greene", "year": "2007", "unstructured": "Greene RE, Schlamm HT, Oestmann JW, et al.: Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign. Clin Infect Dis 2007, 44:373\u2013379.", "journal-title": "Clin Infect Dis"}, {"key": "5_CR52", "doi-asserted-by": "crossref", "first-page": "139", "DOI": "10.1200/JCO.1997.15.1.139", "volume": "15", "author": "D. Caillot", "year": "1997", "unstructured": "Caillot D, Casasnovas O, Bernard A, et al.: Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery. J Clin Oncol 1997, 15:139\u2013147.", "journal-title": "J Clin Oncol"}, {"key": "5_CR53", "doi-asserted-by": "crossref", "first-page": "2", "DOI": "10.1086/508774", "volume": "44", "author": "T.J. Walsh", "year": "2007", "unstructured": "Walsh TJ, Raad I, Patterson TF, et al.: Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial. Clin Infect Dis 2007, 44:2\u201312.", "journal-title": "Clin Infect Dis"}, {"key": "5_CR54", "doi-asserted-by": "crossref", "first-page": "791", "DOI": "10.1097/TP.0b013e3181837585", "volume": "86", "author": "B.D. Alexander", "year": "2008", "unstructured": "Alexander BD, Perfect JR, Daly JS, et al.: Posaconazole as salvage therapy in patients with invasive fungal infections after solid organ transplant. Transplantation 2008, 86:791\u2013796.", "journal-title": "Transplantation"}, {"key": "5_CR55", "doi-asserted-by": "crossref", "first-page": "1122", "DOI": "10.1086/374557", "volume": "36", "author": "J.R. Perfect", "year": "2003", "unstructured": "Perfect JR, Marr KA, Walsh TJ, et al.: Voriconazole treatment for less-common, emerging, or refractory fungal infections. Clin Infect Dis 2003, 36:1122\u20131131.", "journal-title": "Clin Infect Dis"}, {"key": "5_CR56", "doi-asserted-by": "crossref", "first-page": "272", "DOI": "10.1046/j.1365-2141.2000.02312.x", "volume": "111", "author": "C. Girmenia", "year": "2000", "unstructured": "Girmenia C, Pagano L, Corvatta L, et al.: The epidemiology of fusariosis in patients with haematological diseases. Gimema Infection Programme. Br J Haematol 2000, 111:272\u2013276.", "journal-title": "Br J Haematol"}, {"key": "5_CR57", "doi-asserted-by": "crossref", "first-page": "315", "DOI": "10.1002/cncr.11510", "volume": "98", "author": "M. Nucci", "year": "2003", "unstructured": "Nucci M, Anaissie EJ, Queiroz-Telles F, et al.: Outcome predictors of 84 patients with hematologic malignancies and Fusarium infection. Cancer 2003, 98:315\u2013319.", "journal-title": "Cancer"}, {"key": "5_CR58", "doi-asserted-by": "crossref", "first-page": "695", "DOI": "10.1128/CMR.00014-07", "volume": "20", "author": "M. Nucci", "year": "2007", "unstructured": "Nucci M, Anaissie E: Fusarium infections in immunocompromised patients. Clin Microbiol Rev 2007, 20:695\u2013704.", "journal-title": "Clin Microbiol Rev"}, {"key": "5_CR59", "doi-asserted-by": "crossref", "first-page": "77", "DOI": "10.1097/00005792-198803000-00001", "volume": "67", "author": "E. Anaissie", "year": "1988", "unstructured": "Anaissie E, Kantarjian H, Ro J, et al.: The emerging role of Fusarium infections in patients with cancer. Medicine (Baltimore) 1988, 67:77\u201383.", "journal-title": "Medicine (Baltimore)"}, {"key": "5_CR60", "doi-asserted-by": "crossref", "first-page": "909", "DOI": "10.1086/342328", "volume": "35", "author": "M. Nucci", "year": "2002", "unstructured": "Nucci M, Anaissie E: Cutaneous infection by Fusarium species in healthy and immunocompromised hosts: implications for diagnosis and management. Clin Infect Dis 2002, 35:909\u2013920.", "journal-title": "Clin Infect Dis"}, {"key": "5_CR61", "doi-asserted-by": "crossref", "first-page": "607", "DOI": "10.1097/00001432-200312000-00015", "volume": "16", "author": "M. Nucci", "year": "2003", "unstructured": "Nucci M: Emerging moulds: Fusarium, Scedosporium and Zygomycetes in transplant recipients. Curr Opin Infect Dis 2003, 16:607\u2013612.", "journal-title": "Curr Opin Infect Dis"}, {"key": "5_CR62", "doi-asserted-by": "crossref", "first-page": "1237", "DOI": "10.1086/383319", "volume": "38", "author": "M. Nucci", "year": "2004", "unstructured": "Nucci M, Marr KA, Queiroz-Telles F, et al.: Fusarium infection in hematopoietic stem cell transplant recipients. Clin Infect Dis 2004, 38:1237\u20131242.", "journal-title": "Clin Infect Dis"}, {"key": "5_CR63", "doi-asserted-by": "crossref", "first-page": "1398", "DOI": "10.1086/503425", "volume": "42", "author": "I.I. Raad", "year": "2006", "unstructured": "Raad II, Hachem RY, Herbrecht R, et al.: Posaconazole as salvage treatment for invasive fusariosis in patients with underlying hematologic malignancy and other conditions. Clin Infect Dis 2006, 42:1398\u20131403.", "journal-title": "Clin Infect Dis"}, {"key": "5_CR64", "doi-asserted-by": "crossref", "first-page": "1580", "DOI": "10.1086/509579", "volume": "43", "author": "G.A. Lamaris", "year": "2006", "unstructured": "Lamaris GA, Chamilos G, Lewis RE, et al.: Scedosporium infection in a tertiary care cancer center: a review of 25 cases from 1989\u20132006. Clin Infect Dis 2006, 43:1580\u20131584.", "journal-title": "Clin Infect Dis"}, {"key": "5_CR65", "doi-asserted-by": "crossref", "first-page": "295", "DOI": "10.1080/13693780600752507", "volume": "44", "author": "J. Guarro", "year": "2006", "unstructured": "Guarro J, Kantarcioglu AS, Horre R, et al.: Scedosporium apiospermum: changing clinical spectrum of a therapyrefractory opportunist. Med Mycol 2006, 44:295\u2013327.", "journal-title": "Med Mycol"}, {"key": "5_CR66", "doi-asserted-by": "crossref", "first-page": "1648", "DOI": "10.1086/340522", "volume": "34", "author": "I.K. Mellinghoff", "year": "2002", "unstructured": "Mellinghoff IK, Winston DJ, Mukwaya G, Schiller GJ: Treatment of Scedosporium apiospermum brain abscesses with posaconazole. Clin Infect Dis 2002, 34:1648\u20131650.", "journal-title": "Clin Infect Dis"}, {"key": "5_CR67", "doi-asserted-by": "crossref", "first-page": "5157", "DOI": "10.1128/AAC.49.12.5157-5159.2005", "volume": "49", "author": "K. Heyn", "year": "2005", "unstructured": "Heyn K, Tredup A, Salvenmoser S, Muller FM: Effect of voriconazole combined with micafungin against Candida, Aspergillus, and Scedosporium spp. and Fusarium solani. Antimicrob Agents Chemother 2005, 49:5157\u20135159.", "journal-title": "Antimicrob Agents Chemother"}, {"key": "5_CR68", "doi-asserted-by": "crossref", "first-page": "83", "DOI": "10.1007/s11046-008-9131-2", "volume": "166", "author": "M.R. Nanda-Rajah", "year": "2008", "unstructured": "Nanda-Rajah MR, Grigg A, Slavin MA: Breakthrough disseminated Scedosporium prolificans infection in a patient with relapsed leukaemia on prolonged voriconazole followed by posaconazole prophylaxis. Mycopathologia 2008, 166:83\u201386.", "journal-title": "Mycopathologia"}, {"issue": "Suppl1", "key": "5_CR69", "doi-asserted-by": "crossref", "first-page": "48", "DOI": "10.1111/j.1470-9465.2004.00839.x", "volume": "10", "author": "T.J. Walsh", "year": "2004", "unstructured": "Walsh TJ, Groll A, Hiemenz J, et al.: Infections due to emerging and uncommon medically important fungal pathogens. Clin Microbiol Infect 2004, 10(Suppl 1):48\u201366.", "journal-title": "Clin Microbiol Infect"}, {"key": "5_CR70", "doi-asserted-by": "crossref", "first-page": "239", "DOI": "10.1080/02681219880000361", "volume": "36", "author": "M.R. McGinnis", "year": "1998", "unstructured": "McGinnis MR, Pasarell L, Sutton DA, et al.: In vitro activity of voriconazole against selected fungi. Med Mycol 1998, 36:239\u2013242.", "journal-title": "Med Mycol"}, {"key": "5_CR71", "first-page": "2353", "volume": "36", "author": "M.R. McGinnis", "year": "1998", "unstructured": "McGinnis MR, Pasarell L: In vitro testing of susceptibilities of filamentous ascomycetes to voriconazole, itraconazole, and amphotericin B, with consideration of phylogenetic implications. J Clin Microbiol 1998, 36:2353\u20132355.", "journal-title": "J Clin Microbiol"}, {"key": "5_CR72", "doi-asserted-by": "crossref", "first-page": "519", "DOI": "10.1111/j.1439-0507.2006.01304.x", "volume": "49", "author": "L.A. Proia", "year": "2006", "unstructured": "Proia LA, Trenholme GM: Chronic refractory phaeohyphomycosis: successful treatment with posaconazole. Mycoses 2006, 49:519\u2013522.", "journal-title": "Mycoses"}, {"key": "5_CR73", "doi-asserted-by": "crossref", "first-page": "1553", "DOI": "10.2165/00003495-200565110-00007", "volume": "65", "author": "G.M. Keating", "year": "2005", "unstructured": "Keating GM: Posaconazole. Drugs 2005, 65:1553\u20131567.", "journal-title": "Drugs"}, {"key": "5_CR74", "doi-asserted-by": "crossref", "first-page": "634", "DOI": "10.1086/432579", "volume": "41", "author": "M.M. Roden", "year": "2005", "unstructured": "Roden MM, Zaoutis TE, Buchanan WL, et al.: Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis 2005, 41:634\u2013653.", "journal-title": "Clin Infect Dis"}, {"key": "5_CR75", "doi-asserted-by": "crossref", "first-page": "126", "DOI": "10.1128/AAC.50.1.126-133.2006", "volume": "50", "author": "R.N. Greenberg", "year": "2006", "unstructured": "Greenberg RN, Mullane K, van Burik JA, et al.: Posaconazole as salvage therapy for zygomycosis. Antimicrob Agents Chemother 2006, 50:126\u2013133.", "journal-title": "Antimicrob Agents Chemother"}, {"key": "5_CR76", "doi-asserted-by": "crossref", "first-page": "e61", "DOI": "10.1086/500212", "volume": "42", "author": "J.A. Burik van", "year": "2006", "unstructured": "van Burik JA, Hare RS, Solomon HF, et al.: Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases. Clin Infect Dis 2006, 42:e61\u2013e65.", "journal-title": "Clin Infect Dis"}, {"key": "5_CR77", "doi-asserted-by": "crossref", "first-page": "529", "DOI": "10.1128/JCM.44.2.529-535.2006", "volume": "44", "author": "S.S. Magill", "year": "2006", "unstructured": "Magill SS, Shields C, Sears CL, et al.: Triazole cross-resistance among Candida spp.: case report, occurrence among bloodstream isolates, and implications for antifungal therapy. J Clin Microbiol 2006, 44:529\u2013535.", "journal-title": "J Clin Microbiol"}, {"key": "5_CR78", "doi-asserted-by": "crossref", "first-page": "201", "DOI": "10.1016/j.diagmicrobio.2003.09.008", "volume": "48", "author": "M.A. Pfaller", "year": "2004", "unstructured": "Pfaller MA, Messer SA, Boyken L, et al.: In vitro activities of voriconazole, posaconazole, and fluconazole against 4,169 clinical isolates of Candida spp. and Cryptococcus neoformans collected during 2001 and 2002 in the ARTEMIS global antifungal surveillance program. Diagn Microbiol Infect Dis 2004, 48:201\u2013205", "journal-title": "Diagn Microbiol Infect Dis"}, {"key": "5_CR79", "doi-asserted-by": "crossref", "first-page": "1144", "DOI": "10.1093/jac/dki393", "volume": "56", "author": "A. Perkins", "year": "2005", "unstructured": "Perkins A, Gomez-Lopez A, Mellado E, et al.: Rates of antifungal resistance among Spanish clinical isolates of Cryptococcus neoformans var. neoformans. J Antimicrob Chemother 2005, 56:1144\u20131147.", "journal-title": "J Antimicrob Chemother"}, {"key": "5_CR80", "doi-asserted-by": "crossref", "first-page": "2163", "DOI": "10.1128/JCM.43.5.2163-2167.2005", "volume": "43", "author": "M.A. Pfaller", "year": "2005", "unstructured": "Pfaller MA, Messer SA, Boyken L, et al.: Global trends in the antifungal susceptibility of Cryptococcus neoformans (1990 to 2004). J Clin Microbiol 2005, 43:2163\u20132167.", "journal-title": "J Clin Microbiol"}, {"key": "5_CR81", "doi-asserted-by": "crossref", "first-page": "3039", "DOI": "10.1128/AAC.46.9.3039-3041.2002", "volume": "46", "author": "S. Perea", "year": "2002", "unstructured": "Perea S, Gonzalez G, Fothergill AW, et al.: In vitro interaction of caspofungin acetate with voriconazole against clinical isolates of Aspergillus spp. Antimicrob Agents Chemother 2002, 46:3039\u20133041.", "journal-title": "Antimicrob Agents Chemother"}, {"key": "5_CR82", "doi-asserted-by": "crossref", "first-page": "3623", "DOI": "10.1128/JCM.41.8.3623-3626.2003", "volume": "41", "author": "D.J. Diekema", "year": "2003", "unstructured": "Diekema DJ, Messer SA, Hollis RJ, et al.: Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungi. J Clin Microbiol 2003, 41:3623\u20133626.", "journal-title": "J Clin Microbiol"}, {"key": "5_CR83", "doi-asserted-by": "crossref", "first-page": "309", "DOI": "10.1111/j.1439-0507.1998.tb00344.x", "volume": "41", "author": "A. Wildfeuer", "year": "1998", "unstructured": "Wildfeuer A, Seidl HP, Paule I, Haberreiter A: In vitro evaluation of voriconazole against clinical isolates of yeasts, moulds and dermatophytes in comparison with itraconazole, ketoconazole, amphotericin B and griseofulvin. Mycoses 1998, 41:309\u2013319.", "journal-title": "Mycoses"}], "container-title": ["Current Fungal Infection Reports"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1007/s12281-009-0005-y.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/article/10.1007/s12281-009-0005-y/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1007/s12281-009-0005-y", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 6, 3]], "date-time": "2019-06-03T16:37:15Z", "timestamp": 1559579835000}, "score": 27.655628, "issued": {"date-parts": [[2009, 2, 14]]}, "references-count": 83, "journal-issue": {"published-print": {"date-parts": [[2009, 3]]}, "issue": "1"}, "alternative-id": ["5"], "URL": "http://dx.doi.org/10.1007/s12281-009-0005-y", "relation": {"cites": []}, "ISSN": ["1936-3761", "1936-377X"], "issn-type": [{"value": "1936-3761", "type": "print"}, {"value": "1936-377X", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T20:13:03Z", "timestamp": 1574885583448}, "reference-count": 0, "publisher": "American Society for Microbiology", "issue": "12", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Antimicrob. Agents Chemother."], "published-print": {"date-parts": [[1998, 12, 1]]}, "abstract": "<jats:p>BMS-207147, Sch 56592, and voriconazole are three new investigational triazoles with broad-spectrum antifungal activity. The in vitro activities of these three agents were compared with those of itraconazole and fluconazole against 1,300 bloodstream isolates of<jats:italic>Candida</jats:italic> species obtained from over 50 different medical centers in the United States. The MICs of all of the antifungal drugs were determined by broth microdilution tests performed according to the National Committee for Clinical Laboratory Standards method using RPMI 1640 as a test medium. BMS-207147, Sch 56592, and voriconazole were all quite active against all <jats:italic>Candida</jats:italic> sp. isolates (MICs for 90% of the isolates tested [MIC<jats:sub>90</jats:sub>s], 0.5, 1.0, and 0.5 \u03bcg/ml, respectively). <jats:italic>Candida albicans</jats:italic> was the most susceptible species (MIC<jats:sub>90</jats:sub>s, 0.03, 0.06, and 0.06 \u03bcg/ml, respectively), and <jats:italic>C. glabrata</jats:italic> was the least susceptible (MIC<jats:sub>90</jats:sub>s, 4.0, 4.0, and 2.0 \u03bcg/ml, respectively). BMS-207147, Sch 56592, and voriconazole were all more active than itraconazole and fluconazole against <jats:italic>C. albicans</jats:italic>, <jats:italic>C. parapsilosis</jats:italic>, <jats:italic>C. tropicalis</jats:italic>, and <jats:italic>C. krusei</jats:italic>. There existed a clear rank order of in vitro activity of the five azoles examined in this study when they were tested versus<jats:italic>C. glabrata</jats:italic>: voriconazole &gt; BMS-207147 = Sch 56592 = itraconazole &gt; fluconazole (MIC<jats:sub>90</jats:sub>s, 2.0, 4.0, 4.0, 4.0, and 64 \u03bcg/ml, respectively). For isolates of<jats:italic>Candida</jats:italic> spp. with decreased susceptibility to both itraconazole and fluconazole, the MICs of BMS-207147, Sch 56592, and voriconazole were also elevated. These results suggest that BMS-207147, Sch 56592, and voriconazole all possess promising antifungal activity and that further in vitro and in vivo investigations are warranted to establish the clinical value of this improved potency.</jats:p>", "DOI": "10.1128/aac.42.12.3242", "type": "journal-article", "created": {"date-parts": [[2018, 10, 9]], "date-time": "2018-10-09T00:29:51Z", "timestamp": 1539044991000}, "page": "3242-3244", "source": "Crossref", "is-referenced-by-count": 49, "title": ["In Vitro Susceptibilities of CandidaBloodstream Isolates to the New Triazole Antifungal Agents BMS-207147, Sch 56592, and Voriconazole"], "prefix": "10.1128", "volume": "42", "author": [{"given": "M. A.", "family": "Pfaller", "sequence": "first", "affiliation": []}, {"given": "S. A.", "family": "Messer", "sequence": "additional", "affiliation": []}, {"given": "R. J.", "family": "Hollis", "sequence": "additional", "affiliation": []}, {"given": "R. N.", "family": "Jones", "sequence": "additional", "affiliation": []}, {"given": "G. V.", "family": "Doern", "sequence": "additional", "affiliation": []}, {"given": "M. E.", "family": "Brandt", "sequence": "additional", "affiliation": []}, {"given": "R. A.", "family": "Hajjeh", "sequence": "additional", "affiliation": []}], "member": "235", "published-online": {"date-parts": [[1998, 12, 1]]}, "container-title": ["Antimicrobial Agents and Chemotherapy"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1128/AAC.42.12.3242", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 10, 9]], "date-time": "2018-10-09T00:31:17Z", "timestamp": 1539045077000}, "score": 23.419325, "issued": {"date-parts": [[1998, 12, 1]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[1998, 12, 1]]}, "published-print": {"date-parts": [[1998, 12, 1]]}, "issue": "12"}, "alternative-id": ["10.1128/AAC.42.12.3242"], "URL": "http://dx.doi.org/10.1128/aac.42.12.3242", "ISSN": ["0066-4804", "1098-6596"], "issn-type": [{"value": "0066-4804", "type": "print"}, {"value": "1098-6596", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T11:56:00Z", "timestamp": 1574164560457}, "reference-count": 25, "publisher": "Informa Healthcare", "issue": "4", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Current Medical Research and Opinion"], "published-print": {"date-parts": [[2003, 1]]}, "DOI": "10.1185/030079903125001884", "type": "journal-article", "created": {"date-parts": [[2003, 6, 13]], "date-time": "2003-06-13T21:04:34Z", "timestamp": 1055538274000}, "page": "263-271", "source": "Crossref", "is-referenced-by-count": 51, "title": ["Review of the safety, tolerability, and drug interactions of the new antifungal agents caspofungin and voriconazole"], "prefix": "10.1185", "volume": "19", "author": [{"given": "Andrew J.", "family": "Ullmann", "sequence": "first", "affiliation": []}], "member": "3197", "published-online": {"date-parts": [[2008, 9, 22]]}, "container-title": ["Current Medical Research and Opinion"], "language": "en", "link": [{"URL": "http://www.tandfonline.com/doi/pdf/10.1185/030079903125001884", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 13]], "date-time": "2016-12-13T08:37:18Z", "timestamp": 1481618238000}, "score": 22.835485, "issued": {"date-parts": [[2003, 1]]}, "references-count": 25, "journal-issue": {"published-online": {"date-parts": [[2008, 9, 22]]}, "published-print": {"date-parts": [[2003, 1]]}, "issue": "4"}, "alternative-id": ["10.1185/030079903125001884"], "URL": "http://dx.doi.org/10.1185/030079903125001884", "ISSN": ["0300-7995", "1473-4877"], "issn-type": [{"value": "0300-7995", "type": "print"}, {"value": "1473-4877", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T02:17:36Z", "timestamp": 1574129856314}, "reference-count": 0, "publisher": "American Society for Microbiology", "issue": "5", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Journal of Clinical Microbiology"], "published-print": {"date-parts": [[2002, 5, 1]]}, "DOI": "10.1128/jcm.40.5.1694-1697.2002", "type": "journal-article", "created": {"date-parts": [[2002, 7, 27]], "date-time": "2002-07-27T10:09:29Z", "timestamp": 1027764569000}, "page": "1694-1697", "source": "Crossref", "is-referenced-by-count": 8, "title": ["Clinical Evaluation of a Frozen Commercially Prepared Microdilution Panel for Antifungal Susceptibility Testing of Seven Antifungal Agents, Including the New Triazoles Posaconazole, Ravuconazole, and Voriconazole"], "prefix": "10.1128", "volume": "40", "author": [{"given": "M. A.", "family": "Pfaller", "sequence": "first", "affiliation": []}, {"given": "D. J.", "family": "Diekema", "sequence": "additional", "affiliation": []}, {"given": "S. A.", "family": "Messer", "sequence": "additional", "affiliation": []}, {"given": "L.", "family": "Boyken", "sequence": "additional", "affiliation": []}, {"given": "H.", "family": "Huynh", "sequence": "additional", "affiliation": []}, {"given": "R. J.", "family": "Hollis", "sequence": "additional", "affiliation": []}], "member": "235", "container-title": ["Journal of Clinical Microbiology"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1128/JCM.40.5.1694-1697.2002", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 23]], "date-time": "2016-12-23T06:47:19Z", "timestamp": 1482475639000}, "score": 21.280901, "issued": {"date-parts": [[2002, 5, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2002, 5, 1]]}, "issue": "5"}, "URL": "http://dx.doi.org/10.1128/jcm.40.5.1694-1697.2002", "ISSN": ["0095-1137"], "issn-type": [{"value": "0095-1137", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T20:56:58Z", "timestamp": 1574110618490}, "reference-count": 0, "publisher": "American Chemical Society (ACS)", "issue": "1", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Org. Process Res. Dev."], "published-print": {"date-parts": [[2001, 1]]}, "DOI": "10.1021/op0000879", "type": "journal-article", "created": {"date-parts": [[2002, 7, 26]], "date-time": "2002-07-26T04:54:32Z", "timestamp": 1027659272000}, "page": "28-36", "source": "Crossref", "is-referenced-by-count": 43, "title": ["Process Development of Voriconazole:\u00a0 A Novel Broad-Spectrum Triazole Antifungal Agent"], "prefix": "10.1021", "volume": "5", "author": [{"given": "Mike", "family": "Butters", "sequence": "first", "affiliation": []}, {"given": "Julie", "family": "Ebbs", "sequence": "additional", "affiliation": []}, {"given": "Stuart P.", "family": "Green", "sequence": "additional", "affiliation": []}, {"given": "Julie", "family": "MacRae", "sequence": "additional", "affiliation": []}, {"given": "Matthew C.", "family": "Morland", "sequence": "additional", "affiliation": []}, {"given": "Charles W.", "family": "Murtiashaw", "sequence": "additional", "affiliation": []}, {"given": "Alan J.", "family": "Pettman", "sequence": "additional", "affiliation": []}], "member": "316", "container-title": ["Organic Process Research & Development"], "language": "en", "link": [{"URL": "https://pubs.acs.org/doi/pdf/10.1021/op0000879", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 9, 28]], "date-time": "2019-09-28T21:35:51Z", "timestamp": 1569706551000}, "score": 21.163334, "issued": {"date-parts": [[2001, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2001, 1]]}, "issue": "1"}, "alternative-id": ["10.1021/op0000879"], "URL": "http://dx.doi.org/10.1021/op0000879", "ISSN": ["1083-6160", "1520-586X"], "issn-type": [{"value": "1083-6160", "type": "print"}, {"value": "1520-586X", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T14:28:00Z", "timestamp": 1574432880823}, "reference-count": 1, "publisher": "Wiley", "issue": "23", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 1924, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["ChemInform"], "DOI": "10.1002/chin.200123120", "type": "journal-article", "created": {"date-parts": [[2010, 5, 29]], "date-time": "2010-05-29T11:49:07Z", "timestamp": 1275133747000}, "page": "no-no", "source": "Crossref", "is-referenced-by-count": 0, "title": ["ChemInform Abstract: Process Development of Voriconazole: A Novel Broad-Spectrum Triazole Antifungal Agent."], "prefix": "10.1002", "volume": "32", "author": [{"given": "Mike", "family": "Butters", "sequence": "first", "affiliation": []}, {"given": "Julie", "family": "Ebbs", "sequence": "additional", "affiliation": []}, {"given": "Stuart P.", "family": "Green", "sequence": "additional", "affiliation": []}, {"given": "Julie", "family": "MacRae", "sequence": "additional", "affiliation": []}, {"given": "Matthew C.", "family": "Morland", "sequence": "additional", "affiliation": []}, {"given": "Charles W.", "family": "Murtiashaw", "sequence": "additional", "affiliation": []}, {"given": "Alan J.", "family": "Pettman", "sequence": "additional", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2010, 5, 26]]}, "reference": [{"key": "10.1002/chin.200123120-BIB1|cit1", "doi-asserted-by": "crossref", "first-page": "28", "DOI": "10.1021/op0000879", "article-title": "Process Development of Voriconazole: A Novel Broad-Spectrum Triazole Antifungal Agent.", "volume": "5", "author": "Butters", "year": "2001", "journal-title": "Org. Process Res. Dev."}], "container-title": ["ChemInform"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fchin.200123120", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://onlinelibrary.wiley.com/doi/full/10.1002/chin.200123120", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 3, 1]], "date-time": "2019-03-01T00:47:32Z", "timestamp": 1551401252000}, "score": 21.163334, "issued": {"date-parts": [[2010, 5, 26]]}, "references-count": 1, "journal-issue": {"issue": "23"}, "URL": "http://dx.doi.org/10.1002/chin.200123120", "relation": {"cites": []}, "ISSN": ["0931-7597", "1522-2667"], "issn-type": [{"value": "0931-7597", "type": "print"}, {"value": "1522-2667", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T22:32:51Z", "timestamp": 1574461971080}, "reference-count": 1, "publisher": "Wiley", "issue": "17", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 1838, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["ChemInform"], "DOI": "10.1002/chin.199317167", "type": "journal-article", "created": {"date-parts": [[2010, 9, 4]], "date-time": "2010-09-04T14:35:24Z", "timestamp": 1283610924000}, "page": "no-no", "source": "Crossref", "is-referenced-by-count": 0, "title": ["ChemInform Abstract: New Triazole Antifungal Agents Derived from Mercaptomethylisoxazoles."], "prefix": "10.1002", "volume": "24", "author": [{"given": "M.", "family": "MORENO-MANAS", "sequence": "first", "affiliation": []}, {"given": "Y.", "family": "ARREDONDO", "sequence": "additional", "affiliation": []}, {"given": "R.", "family": "PLEIXATS", "sequence": "additional", "affiliation": []}, {"given": "M.", "family": "TEIXIDO", "sequence": "additional", "affiliation": []}, {"given": "M. M.", "family": "RAGA", "sequence": "additional", "affiliation": []}, {"given": "C.", "family": "PALACIN", "sequence": "additional", "affiliation": []}, {"given": "J. M.", "family": "CASTELLO", "sequence": "additional", "affiliation": []}, {"given": "J. A.", "family": "ORTIZ", "sequence": "additional", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2010, 8, 20]]}, "reference": [{"key": "10.1002/chin.199317167-BIB1|cit1", "doi-asserted-by": "crossref", "first-page": "1557", "DOI": "10.1002/jhet.5570290631", "article-title": "New Triazole Antifungal Agents Derived from Mercaptomethylisoxazoles.", "volume": "29", "author": "MORENO-MANAS", "year": "1992", "journal-title": "J. Heterocycl. Chem."}], "container-title": ["ChemInform"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fchin.199317167", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://onlinelibrary.wiley.com/doi/full/10.1002/chin.199317167", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 3, 4]], "date-time": "2019-03-04T08:03:43Z", "timestamp": 1551686623000}, "score": 20.97987, "issued": {"date-parts": [[2010, 8, 20]]}, "references-count": 1, "journal-issue": {"issue": "17"}, "URL": "http://dx.doi.org/10.1002/chin.199317167", "relation": {"cites": []}, "ISSN": ["0931-7597"], "issn-type": [{"value": "0931-7597", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 24]], "date-time": "2019-11-24T07:23:31Z", "timestamp": 1574580211442}, "reference-count": 0, "publisher": "Clarivate Analytics (US)", "issue": "12", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Drugs Fut"], "published-print": {"date-parts": [[1989]]}, "DOI": "10.1358/dof.1989.014.12.109655", "type": "journal-article", "created": {"date-parts": [[2015, 2, 6]], "date-time": "2015-02-06T05:28:49Z", "timestamp": 1423200529000}, "page": "1187", "source": "Crossref", "is-referenced-by-count": 21, "title": ["SAPERCONAZOLE, A NEW POTENT ANTIFUNGAL TRIAZOLE: IN VITRO ACTIVITY SPECTRUM AND THERAPEUTIC EFFICACY"], "prefix": "10.1358", "volume": "14", "author": [{"given": "J.", "family": "Van Cutsem", "sequence": "first", "affiliation": []}, {"given": "F.", "family": "Van Gerven", "sequence": "additional", "affiliation": []}, {"given": "P.A.J.", "family": "Janssen", "sequence": "additional", "affiliation": []}], "member": "71", "container-title": ["Drugs of the Future"], "language": "en", "deposited": {"date-parts": [[2015, 2, 6]], "date-time": "2015-02-06T05:28:56Z", "timestamp": 1423200536000}, "score": 20.873198, "issued": {"date-parts": [[1989]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1989]]}, "issue": "12"}, "URL": "http://dx.doi.org/10.1358/dof.1989.014.12.109655", "ISSN": ["0377-8282"], "issn-type": [{"value": "0377-8282", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T00:12:32Z", "timestamp": 1574295152870}, "reference-count": 65, "publisher": "Future Medicine Ltd", "issue": "3", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Future Microbiology"], "published-print": {"date-parts": [[2007, 6]]}, "DOI": "10.2217/17460913.2.3.231", "type": "journal-article", "created": {"date-parts": [[2007, 5, 25]], "date-time": "2007-05-25T07:38:10Z", "timestamp": 1180078690000}, "page": "231-243", "source": "Crossref", "is-referenced-by-count": 24, "title": ["Posaconazole: a next-generation triazole antifungal"], "prefix": "10.2217", "volume": "2", "author": [{"given": "Fedja", "family": "Farowski", "sequence": "first", "affiliation": []}, {"given": "J\u00f6rg J", "family": "Vehreschild", "sequence": "additional", "affiliation": []}, {"given": "Oliver A", "family": "Cornely", "sequence": "additional", "affiliation": []}], "member": "1057", "reference": [{"key": "ref-1", "DOI": "10.1128/JCM.42.10.4419-4431.2004", "doi-asserted-by": "publisher"}, {"key": "ref-2", "author": "Latge", "volume": "12", "first-page": "310", "year": "1999", "journal-title": "Clin.\u00a0Microbiol. Rev.", "DOI": "10.1128/CMR.12.2.310", "doi-asserted-by": "crossref"}, {"key": "ref-3", "DOI": "10.1086/318483", "doi-asserted-by": "publisher"}, {"key": "ref-4", "DOI": "10.1086/513943", "doi-asserted-by": "publisher"}, {"key": "ref-5", "DOI": "10.1086/421946", "doi-asserted-by": "publisher"}, {"key": "ref-6", "DOI": "10.1086/378745", "doi-asserted-by": "publisher"}, {"key": "ref-7", "DOI": "10.1128/CMR.13.2.236-301.2000", "doi-asserted-by": "publisher"}, {"key": "ref-8", "DOI": "10.1007/s10096-006-0107-1", "doi-asserted-by": "publisher"}, {"key": "ref-9", "DOI": "10.1086/432579", "doi-asserted-by": "publisher"}, {"key": "ref-10", "DOI": "10.1128/AAC.48.10.3690-3696.2004", "doi-asserted-by": "publisher"}, {"key": "ref-11", "DOI": "10.3109/10408418709104448", "doi-asserted-by": "publisher"}, {"key": "ref-12", "DOI": "10.1128/AAC.48.6.2124-2131.2004", "doi-asserted-by": "publisher"}, {"key": "ref-13", "DOI": "10.1016/j.ejps.2004.01.005", "doi-asserted-by": "publisher"}, {"key": "ref-14", "DOI": "10.1592/phco.26.12.1730", "doi-asserted-by": "publisher"}, {"key": "ref-15", "DOI": "10.1128/AAC.48.2.568-574.2004", "doi-asserted-by": "publisher"}, {"key": "ref-16", "DOI": "10.1128/AAC.47.2.577-581.2003", "doi-asserted-by": "publisher"}, {"key": "ref-17", "author": "Mellado", "year": "2007", "journal-title": "Antimicrob.\u00a0Agents Chemother."}, {"key": "ref-18", "DOI": "10.1093/jac/dkl133", "doi-asserted-by": "publisher"}, {"key": "ref-19", "DOI": "10.1016/j.diagmicrobio.2003.09.008", "doi-asserted-by": "publisher"}, {"key": "ref-20", "DOI": "10.1128/AAC.46.4.1032-1037.2002", "doi-asserted-by": "publisher"}, {"key": "ref-21", "DOI": "10.1128/JCM.41.8.3623-3626.2003", "doi-asserted-by": "publisher"}, {"key": "ref-22", "DOI": "10.1128/AAC.00163-06", "doi-asserted-by": "publisher"}, {"key": "ref-23", "DOI": "10.1128/AAC.44.3.780-782.2000", "doi-asserted-by": "publisher"}, {"key": "ref-24", "DOI": "10.1128/AAC.44.8.2017-2022.2000", "doi-asserted-by": "publisher"}, {"key": "ref-25", "DOI": "10.1128/AAC.45.3.857-869.2001", "doi-asserted-by": "publisher"}, {"key": "ref-26", "author": "Oakley", "volume": "41", "first-page": "1504", "year": "1997", "journal-title": "Antimicrob.\u00a0Agents Chemother.", "DOI": "10.1128/AAC.41.7.1504", "doi-asserted-by": "crossref"}, {"key": "ref-27", "DOI": "10.1086/377210", "doi-asserted-by": "publisher"}, {"key": "ref-28", "DOI": "10.1128/AAC.48.10.3715-3719.2004", "doi-asserted-by": "publisher"}, {"key": "ref-29", "DOI": "10.1128/AAC.48.3.758-764.2004", "doi-asserted-by": "publisher"}, {"key": "ref-30", "DOI": "10.1128/AAC.48.10.4063-4066.2004", "doi-asserted-by": "publisher"}, {"key": "ref-31", "DOI": "10.1093/jac/48.6.769", "doi-asserted-by": "publisher"}, {"key": "ref-32", "DOI": "10.1128/AAC.47.4.1436-1438.2003", "doi-asserted-by": "publisher"}, {"key": "ref-33", "DOI": "10.1128/AAC.44.10.2604-2608.2000", "doi-asserted-by": "publisher"}, {"key": "ref-34", "DOI": "10.1128/AAC.46.7.2310-2312.2002", "doi-asserted-by": "publisher"}, {"key": "ref-35", "DOI": "10.1093/jac/43.4.589", "doi-asserted-by": "publisher"}, {"key": "ref-36", "DOI": "10.1128/AAC.48.6.2288-2291.2004", "doi-asserted-by": "publisher"}, {"key": "ref-37", "author": "Sugar", "volume": "40", "first-page": "1314", "year": "1996", "journal-title": "Antimicrob.\u00a0Agents Chemother.", "DOI": "10.1128/AAC.40.5.1314", "doi-asserted-by": "crossref"}, {"key": "ref-38", "author": "Lutz", "volume": "41", "first-page": "1558", "year": "1997", "journal-title": "Antimicrob.\u00a0Agents Chemother.", "DOI": "10.1128/AAC.41.7.1558", "doi-asserted-by": "crossref"}, {"key": "ref-39", "DOI": "10.1128/AAC.46.5.1352-1356.2002", "doi-asserted-by": "publisher"}, {"key": "ref-40", "author": "Connolly", "volume": "43", "first-page": "322", "year": "1999", "journal-title": "Antimicrob.\u00a0Agents Chemother.", "DOI": "10.1128/AAC.43.2.322", "doi-asserted-by": "crossref"}, {"key": "ref-41", "DOI": "10.1128/AAC.00969-06", "doi-asserted-by": "publisher"}, {"key": "ref-42", "author": "Al-Abdely", "volume": "43", "first-page": "2910", "year": "1999", "journal-title": "Antimicrob.\u00a0Agents Chemother.", "DOI": "10.1128/AAC.43.12.2910", "doi-asserted-by": "crossref"}, {"key": "ref-43", "DOI": "10.1128/AAC.44.1.150-155.2000", "doi-asserted-by": "publisher"}, {"key": "ref-44", "DOI": "10.1128/AAC.47.9.2788-2795.2003", "doi-asserted-by": "publisher"}, {"key": "ref-45", "DOI": "10.2165/00003088-200544020-00006", "doi-asserted-by": "publisher"}, {"key": "ref-46", "DOI": "10.1046/j.1365-2125.2003.01977.x", "doi-asserted-by": "publisher"}, {"key": "ref-47", "DOI": "10.1128/AAC.50.5.1881-1883.2006", "doi-asserted-by": "publisher"}, {"key": "ref-48", "DOI": "10.1177/0091270004271402", "doi-asserted-by": "publisher"}, {"key": "ref-49", "DOI": "10.1128/AAC.00472-06", "doi-asserted-by": "publisher"}, {"key": "ref-50", "author": "Krishna", "year": "2007", "journal-title": "Antimicrob.\u00a0Agents Chemother."}, {"key": "ref-51", "DOI": "10.1128/AAC.48.9.3543-3551.2004", "doi-asserted-by": "publisher"}, {"key": "ref-52", "DOI": "10.1124/dmd.32.2.267", "doi-asserted-by": "publisher"}, {"key": "ref-53", "DOI": "10.1086/504328", "doi-asserted-by": "publisher"}, {"key": "ref-54", "DOI": "10.1128/AAC.50.2.658-666.2006", "doi-asserted-by": "publisher"}, {"key": "ref-55", "DOI": "10.1093/jac/dki288", "doi-asserted-by": "publisher"}, {"key": "ref-56", "DOI": "10.1056/NEJMoa061094", "doi-asserted-by": "publisher"}, {"key": "ref-57", "DOI": "10.1056/NEJMoa061098", "doi-asserted-by": "publisher"}, {"key": "ref-58", "DOI": "10.1086/501457", "doi-asserted-by": "publisher"}, {"key": "ref-59", "DOI": "10.1086/508774", "doi-asserted-by": "publisher"}, {"key": "ref-60", "unstructured": "RaadII, Hanna H, Boktour Met al.: Posaconazole (POS) compared to high dose lipid formulations of amphotericin B (HD-LPAMB) as salvage therapy for invasive aspergillosis (IA) in patients (pts) with hematologic malignancy (HM).ICAAC.CA, USA (2006)."}, {"key": "ref-61", "DOI": "10.1086/500212", "doi-asserted-by": "publisher"}, {"key": "ref-62", "DOI": "10.1128/AAC.50.1.126-133.2006", "doi-asserted-by": "publisher"}, {"key": "ref-63", "DOI": "10.1016/j.ajo.2006.10.048", "doi-asserted-by": "publisher"}, {"key": "ref-64", "DOI": "10.1086/503425", "doi-asserted-by": "publisher"}, {"key": "ref-65", "DOI": "10.1086/511039", "doi-asserted-by": "publisher"}], "container-title": ["Future Microbiology"], "language": "en", "link": [{"URL": "https://www.futuremedicine.com/doi/pdf/10.2217/17460913.2.3.231", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T10:27:24Z", "timestamp": 1574245644000}, "score": 20.338396, "issued": {"date-parts": [[2007, 6]]}, "references-count": 65, "journal-issue": {"published-print": {"date-parts": [[2007, 6]]}, "issue": "3"}, "alternative-id": ["10.2217/17460913.2.3.231"], "URL": "http://dx.doi.org/10.2217/17460913.2.3.231", "relation": {"cites": []}, "ISSN": ["1746-0913", "1746-0921"], "issn-type": [{"value": "1746-0913", "type": "print"}, {"value": "1746-0921", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T08:08:55Z", "timestamp": 1574150935928}, "reference-count": 22, "publisher": "Elsevier BV", "issue": "2", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1994, 6, 1]], "date-time": "1994-06-01T00:00:00Z", "timestamp": 770428800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Diagnostic Microbiology and Infectious Disease"], "published-print": {"date-parts": [[1994, 6]]}, "DOI": "10.1016/0732-8893(94)90116-3", "type": "journal-article", "created": {"date-parts": [[2003, 2, 4]], "date-time": "2003-02-04T20:48:55Z", "timestamp": 1044391735000}, "page": "75-80", "source": "Crossref", "is-referenced-by-count": 12, "title": ["Antifungal activity of a new triazole, D0870, compared with four other antifungal agents tested against clinical isolates of Candida and Torulopsis glabrata"], "prefix": "10.1016", "volume": "19", "author": [{"given": "Michael A.", "family": "Pfaller", "sequence": "first", "affiliation": []}, {"given": "Martha J.", "family": "Bale", "sequence": "additional", "affiliation": []}, {"given": "Barry", "family": "Buschelman", "sequence": "additional", "affiliation": []}, {"given": "Paul", "family": "Rhomberg", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Diagnostic Microbiology and Infectious Disease"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:0732889394901163?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:0732889394901163?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 3, 30]], "date-time": "2019-03-30T02:55:42Z", "timestamp": 1553914542000}, "score": 19.974195, "issued": {"date-parts": [[1994, 6]]}, "references-count": 22, "journal-issue": {"published-print": {"date-parts": [[1994, 6]]}, "issue": "2"}, "alternative-id": ["0732889394901163"], "URL": "http://dx.doi.org/10.1016/0732-8893(94)90116-3", "ISSN": ["0732-8893"], "issn-type": [{"value": "0732-8893", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 19]], "date-time": "2019-12-19T02:23:29Z", "timestamp": 1576722209093}, "reference-count": 37, "publisher": "Wiley", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 4306, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.1046/j.1365-2125.2003.01993.x", "type": "journal-article", "created": {"date-parts": [[2003, 11, 17]], "date-time": "2003-11-17T19:23:52Z", "timestamp": 1069097032000}, "page": "10-16", "source": "Crossref", "is-referenced-by-count": 73, "title": ["Voriconazole, a novel wide-spectrum triazole: oral pharmacokinetics and safety"], "prefix": "10.1111", "volume": "56", "author": [{"given": "Lynn", "family": "Purkins", "sequence": "first", "affiliation": []}, {"given": "Nolan", "family": "Wood", "sequence": "additional", "affiliation": []}, {"given": "Katie", "family": "Greenhalgh", "sequence": "additional", "affiliation": []}, {"given": "Michael J.", "family": "Allen", "sequence": "additional", "affiliation": []}, {"given": "Stuart D.", "family": "Oliver", "sequence": "additional", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2003, 11, 17]]}, "reference": [{"key": "10.1046/j.1365-2125.2003.01993.x-BIB1|cit1", "doi-asserted-by": "crossref", "first-page": "179", "DOI": "10.3109/00365548609032326", "article-title": "Fungal infections in patients with AIDS and AIDS-related complex", "volume": "18", "author": "Holmberg", "year": "1986", "journal-title": "Scand J Infect Dis"}, {"key": "10.1046/j.1365-2125.2003.01993.x-BIB2|cit2", "doi-asserted-by": "crossref", "first-page": "1439", "DOI": "10.1056/NEJM198806023182206", "article-title": "Treatment of infections associated with human immunodeficiency virus", "volume": "318", "author": "Glatt", "year": "1988", "journal-title": "N Engl J Med"}, {"key": "10.1046/j.1365-2125.2003.01993.x-BIB3|cit3", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1093/clinids/16.1.1", "article-title": "Treatment of opportunistic fungal infections", "volume": "16", "author": "Armstrong", "year": "1988", "journal-title": "Clin Infect Dis"}, {"issue": "Suppl 3B", "key": "10.1046/j.1365-2125.2003.01993.x-BIB4|cit4", "doi-asserted-by": "crossref", "first-page": "86S", "DOI": "10.1016/0002-9343(91)90349-3", "article-title": "Secular trends in nosocomial bloodstream infections in the United States, 1980-1989. National Nosocomial Infections Surveillance System", "volume": "91", "author": "Banerjee", "year": "1991", "journal-title": "Am J Med"}, {"key": "10.1046/j.1365-2125.2003.01993.x-BIB5|cit5", "doi-asserted-by": "crossref", "first-page": "1526", "DOI": "10.1093/clinids/20.6.1526", "article-title": "Epidemiology of nosocomial fungal infections, with emphasis on Candida species", "volume": "20", "author": "Jarvis", "year": "1995", "journal-title": "Clin Infect Dis"}, {"key": "10.1046/j.1365-2125.2003.01993.x-BIB6|cit6", "first-page": "1045", "article-title": "Fungal infections in solid organ transplant recipients", "volume": "9", "author": "Hadley", "year": "1995", "journal-title": "Infect Dis Clin N Am"}, {"issue": "Suppl 2", "key": "10.1046/j.1365-2125.2003.01993.x-BIB7|cit7", "doi-asserted-by": "crossref", "first-page": "8", "DOI": "10.1111/j.1469-0691.2001.tb00005.x", "article-title": "Uncommon opportunistic fungi: new nosocomial threats", "volume": "7", "author": "Groll", "year": "2001", "journal-title": "Clin Microbiol Infect"}, {"issue": "Suppl 1", "key": "10.1046/j.1365-2125.2003.01993.x-BIB8|cit8", "doi-asserted-by": "crossref", "first-page": "225", "DOI": "10.1080/mmy.38.s1.225.236", "article-title": "Emerging pathogens", "volume": "38", "author": "Ponton", "year": "2000", "journal-title": "Med Mycol"}, {"key": "10.1046/j.1365-2125.2003.01993.x-BIB9|cit9", "doi-asserted-by": "crossref", "first-page": "78", "DOI": "10.1097/00005792-199303000-00002", "article-title": "The spectrum on non-Candida fungal infections following bone marrow transplantation", "volume": "72", "author": "Morrison", "year": "1993", "journal-title": "Medicine"}, {"key": "10.1046/j.1365-2125.2003.01993.x-BIB10|cit10", "first-page": "226", "article-title": "Fungal infections: a growing threat", "volume": "111", "author": "Dixon", "year": "1996", "journal-title": "Public Health Report"}, {"issue": "Suppl D", "key": "10.1046/j.1365-2125.2003.01993.x-BIB11|cit11", "doi-asserted-by": "crossref", "first-page": "95", "DOI": "10.1093/jac/41.suppl_4.95", "article-title": "Fungal infections in neutropenia: current problems and chemotherapeutic control", "volume": "41", "author": "Warnock", "year": "1998", "journal-title": "J Antimicrob Chemother"}, {"key": "10.1046/j.1365-2125.2003.01993.x-BIB12|cit12", "doi-asserted-by": "crossref", "first-page": "1499", "DOI": "10.1086/317496", "article-title": "Successful outcome of Scedosporium apiospermum disseminated infection treated with voriconazole in a patient receiving corticosteroid therapy", "volume": "31", "author": "Munoz", "year": "2000", "journal-title": "Clin Infect Dis"}, {"key": "10.1046/j.1365-2125.2003.01993.x-BIB13|cit13", "doi-asserted-by": "crossref", "first-page": "1267", "DOI": "10.1016/S0140-6736(00)04423-8", "article-title": "Airborne outbreak of nosocomial Scedosporium prolificans infection", "volume": "357", "author": "Guerrero", "year": "2001", "journal-title": "Lancet"}, {"key": "10.1046/j.1365-2125.2003.01993.x-BIB14|cit14", "doi-asserted-by": "crossref", "first-page": "1147", "DOI": "10.1093/clinids/12.6.1147", "article-title": "Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases", "volume": "11", "author": "Denning", "year": "1990", "journal-title": "Rev Infect Dis"}, {"key": "10.1046/j.1365-2125.2003.01993.x-BIB15|cit15", "doi-asserted-by": "crossref", "first-page": "755", "DOI": "10.1093/clinids/20.4.755", "article-title": "Pretreatment regimens for adverse events related to infusion of amphotericin B", "volume": "20", "author": "Goodwin", "year": "1995", "journal-title": "Clin Infect Dis"}, {"key": "10.1046/j.1365-2125.2003.01993.x-BIB16|cit16", "first-page": "154", "article-title": "Amphotericin B nephrotoxicity: the adverse consequences of altered membrane properties", "volume": "6", "author": "Sawaya", "year": "1995", "journal-title": "J Am Soc Nephrol"}, {"issue": "Suppl 1", "key": "10.1046/j.1365-2125.2003.01993.x-BIB17|cit17", "doi-asserted-by": "crossref", "first-page": "13", "DOI": "10.2165/00003495-200161001-00002", "article-title": "Current management of fungal infections", "volume": "61", "author": "Meis", "year": "2001", "journal-title": "Drugs"}, {"key": "10.1046/j.1365-2125.2003.01993.x-BIB18|cit18", "doi-asserted-by": "crossref", "first-page": "51", "DOI": "10.1034/j.1399-3062.2000.020203.x", "article-title": "Amphotericin B preparations: a maximum tolerated dose in severe invasive fungal infections?", "volume": "2", "author": "Ellis", "year": "2000", "journal-title": "Transpl Infect Dis"}, {"key": "10.1046/j.1365-2125.2003.01993.x-BIB19|cit19", "doi-asserted-by": "crossref", "first-page": "135", "DOI": "10.1016/0002-9343(94)90023-X", "article-title": "NIAID Mycoses Study Group multicenter trial of oral itraconazole therapy for invasive aspergillosis", "volume": "97", "author": "Denning", "year": "1994", "journal-title": "Am J Med"}, {"key": "10.1046/j.1365-2125.2003.01993.x-BIB20|cit20", "doi-asserted-by": "crossref", "first-page": "310", "DOI": "10.2165/00003495-198937030-00003", "article-title": "Itraconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in superficial and systemic mycoses", "volume": "37", "author": "Grant", "year": "1989", "journal-title": "Drugs"}, {"issue": "Suppl 1", "key": "10.1046/j.1365-2125.2003.01993.x-BIB21|cit21", "doi-asserted-by": "crossref", "first-page": "12", "DOI": "10.1159/000239048", "article-title": "US experience with itraconazole in Aspergillus, Cryptococcus and Histoplasma infections in the immunocompromised host", "volume": "38", "author": "Hostetler", "year": "1992", "journal-title": "Chemotherapy"}, {"key": "10.1046/j.1365-2125.2003.01993.x-BIB22|cit22", "doi-asserted-by": "crossref", "first-page": "587", "DOI": "10.1016/0190-9622(90)70260-O", "article-title": "European experience with itraconazole in systemic mycoses", "volume": "23", "author": "Viviani", "year": "1990", "journal-title": "J Am Acad Dermatol"}, {"key": "10.1046/j.1365-2125.2003.01993.x-BIB23|cit23", "doi-asserted-by": "crossref", "first-page": "607", "DOI": "10.1016/0190-9622(90)70263-H", "article-title": "Itraconazole therapy in aspergillosis: study in 49 patients", "volume": "23", "author": "Dupont", "year": "1990", "journal-title": "J Am Acad Dermatol"}, {"key": "10.1046/j.1365-2125.2003.01993.x-BIB24|cit24", "doi-asserted-by": "crossref", "first-page": "720", "DOI": "10.1345/aph.10262", "article-title": "Intravenous itraconazole", "volume": "35", "author": "Slain", "year": "2001", "journal-title": "Ann Pharmacother"}, {"key": "10.1046/j.1365-2125.2003.01993.x-BIB25|cit25", "first-page": "572", "article-title": "Sensitivity of Aspergillus to ketoconazole and itraconazole using a standardized micromethod", "volume": "38", "author": "Guinet", "year": "1990", "journal-title": "Pathol Biol (Paris)"}, {"key": "10.1046/j.1365-2125.2003.01993.x-BIB26|cit26", "doi-asserted-by": "crossref", "first-page": "147", "DOI": "10.1007/BF00576365", "article-title": "Determination of the minimal inhibitory concentration of amphotericin B and miconazole for 21 strains of Aspergillus", "volume": "64", "author": "Martinez", "year": "1978", "journal-title": "Mycopathologia"}, {"key": "10.1046/j.1365-2125.2003.01993.x-BIB27|cit27", "author": "Bennett", "first-page": "1165", "year": "1990", "volume-title": "Goodman and Gilman's the Pharmacological Basis of Therapeutics"}, {"key": "10.1046/j.1365-2125.2003.01993.x-BIB28|cit28", "first-page": "5", "article-title": "Chemoprophylaxis for candidosis and aspergillosis in neutropenia and transplantation: a review and recommendations", "volume": "32", "author": "British Society for Antimicrobial Chemotherapy Working Party.", "year": "1992", "journal-title": "J Antimicrob Chemother"}, {"key": "10.1046/j.1365-2125.2003.01993.x-BIB29|cit29", "doi-asserted-by": "crossref", "first-page": "531", "DOI": "10.1093/jac/42.4.531", "article-title": "Comparison of the in vitro activity of voriconazole (UK-109,496), itraconazole and amphotericin B against clinical isolates of Aspergillus fumigatus", "volume": "42", "author": "Cuenca-Estrella", "year": "1998", "journal-title": "J Antimicrob Chemother"}, {"key": "10.1046/j.1365-2125.2003.01993.x-BIB30|cit30", "first-page": "198", "article-title": "In vitro activity of the new triazole voriconazole (UK-109496) against opportunistic filamentous and dimorphic fungi and common and emerging yeast pathogens", "volume": "36", "author": "Espinel-Ingroff", "year": "1998", "journal-title": "J Clin Microbiol"}, {"key": "10.1046/j.1365-2125.2003.01993.x-BIB31|cit31", "doi-asserted-by": "crossref", "first-page": "135", "DOI": "10.1358/dot.2001.37.2.614849", "article-title": "Voriconazole: a second-generation triazole", "volume": "37", "author": "Chandrasekar", "year": "2001", "journal-title": "Drugs Today"}, {"key": "10.1046/j.1365-2125.2003.01993.x-BIB32|cit32", "unstructured": "Torre-Cisneros J Gonzalez-Ruiz A Hodges MR Lutsar I. Voriconazole (VORI) for the treatment of S. apiospermum and S. prolificans infection Program and Abstracts of the 38th Annual Meeting of the Infectious Diseases Society of America September 2000"}, {"key": "10.1046/j.1365-2125.2003.01993.x-BIB33|cit33", "unstructured": "Perfect J Gonzalez-Ruiz A Lutsar I. Voriconazole (VORI) for the treatment of resistant and rare fungal pathogens Program and Abstracts of the 38th Annual Meeting of the Infectious Diseases Society of America September 2000"}, {"key": "10.1046/j.1365-2125.2003.01993.x-BIB34|cit34", "doi-asserted-by": "crossref", "first-page": "441", "DOI": "10.1016/S0378-4347(96)00408-2", "article-title": "Determination of a new antifungal agent, voriconazole, by multidimensional high-performance liquid chromatography with direct plasma injection onto a size-exclusion column", "volume": "691", "author": "Stopher", "year": "1997", "journal-title": "J Chromatogr B Biomed Sci Appl"}, {"key": "10.1046/j.1365-2125.2003.01993.x-BIB35|cit35", "year": "1989", "volume-title": "SAS/STAT User's Guide"}, {"key": "10.1046/j.1365-2125.2003.01993.x-BIB36|cit36", "unstructured": "Hitchcock CA Pye GW Oliver GP Troke PF. UK-109,496, a novel, wide-spectrum triazole derivative for the treatment of fungal infections: antifungal activity and selectivity in vitro Program and Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy San Francisco September 1995"}, {"key": "10.1046/j.1365-2125.2003.01993.x-BIB37|cit37", "first-page": "40", "article-title": "Current and emerging azole antifungal agents", "volume": "12", "author": "Sheehan", "year": "1999", "journal-title": "Clin Microbiol Rev"}], "container-title": ["British Journal of Clinical Pharmacology"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1365-2125.2003.01993.x", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 3, 24]], "date-time": "2018-03-24T03:33:58Z", "timestamp": 1521862438000}, "score": 19.234941, "subtitle": ["Pharmacokinetics and safety of oral voriconazole"], "issued": {"date-parts": [[2003, 11, 17]]}, "references-count": 37, "URL": "http://dx.doi.org/10.1046/j.1365-2125.2003.01993.x", "relation": {"cites": []}, "ISSN": ["0306-5251", "1365-2125"], "issn-type": [{"value": "0306-5251", "type": "print"}, {"value": "1365-2125", "type": "electronic"}], "subject": ["Pharmacology (medical)", "Pharmacology"]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T18:15:07Z", "timestamp": 1574360107647}, "reference-count": 0, "publisher": "Oxford University Press (OUP)", "issue": "6", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Journal of Antimicrobial Chemotherapy"], "DOI": "10.1093/jac/dkn129", "type": "journal-article", "created": {"date-parts": [[2008, 3, 27]], "date-time": "2008-03-27T00:14:49Z", "timestamp": 1206576889000}, "page": "1309-1311", "source": "Crossref", "is-referenced-by-count": 7, "title": ["Post-antifungal effect of amphotericin B and voriconazole against germinated Aspergillus fumigatus conidia"], "prefix": "10.1093", "volume": "61", "author": [{"given": "E.", "family": "Chryssanthou", "sequence": "first", "affiliation": []}, {"given": "A.", "family": "Loebig", "sequence": "additional", "affiliation": []}, {"given": "J.", "family": "Sjolin", "sequence": "additional", "affiliation": []}], "member": "286", "published-online": {"date-parts": [[2008, 3, 13]]}, "container-title": ["Journal of Antimicrobial Chemotherapy"], "language": "en", "link": [{"URL": "http://academic.oup.com/jac/article-pdf/61/6/1309/2229585/dkn129.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 8, 23]], "date-time": "2017-08-23T03:30:35Z", "timestamp": 1503459035000}, "score": 19.197998, "issued": {"date-parts": [[2008, 3, 13]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2008, 3, 13]]}, "issue": "6"}, "URL": "http://dx.doi.org/10.1093/jac/dkn129", "ISSN": ["0305-7453", "1460-2091"], "issn-type": [{"value": "0305-7453", "type": "print"}, {"value": "1460-2091", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T12:41:57Z", "timestamp": 1574167317348}, "reference-count": 16, "publisher": "Wiley", "issue": "98", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 4626, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["New Directions for Evaluation"], "published-print": {"date-parts": [[2003]]}, "DOI": "10.1002/ev.81", "type": "journal-article", "created": {"date-parts": [[2003, 7, 1]], "date-time": "2003-07-01T10:02:39Z", "timestamp": 1057053759000}, "page": "13-24", "source": "Crossref", "is-referenced-by-count": 10, "title": ["A Vygotskian Perspective on Youth Participatory Evaluation"], "prefix": "10.1002", "volume": "2003", "author": [{"given": "Kim", "family": "Sabo", "sequence": "first", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2003, 6, 30]]}, "reference": [{"key": "BIB1", "author": "Bruner", "year": "1996", "unstructured": "The Culture of Education. Cambridge, Mass.: Harvard University Press, 1996.", "volume-title": "The Culture of Education"}, {"key": "BIB2", "author": "Cole", "year": "1996", "unstructured": "Cultural Psychology: A Once and Future Discipline. Cambridge, Mass.: Harvard University Press, 1996.", "volume-title": "Cultural Psychology: A Once and Future Discipline"}, {"key": "BIB3", "author": "Heath", "volume": "1", "first-page": "33", "year": "2000", "journal-title": "Afterschool Matters: Dialogues in Philosophy, Practice, and Evaluation"}, {"key": "BIB4", "author": "Holzman", "year": "1997", "unstructured": "Schools for Growth: Radical Alternatives to Current Educational Models. Mahwah, N.J.: Lawrence Erlbaum, 1997.", "volume-title": "Schools for Growth: Radical Alternatives to Current Educational Models"}, {"key": "BIB5", "author": "Holzman", "first-page": "49", "year": "1999", "unstructured": "?Life as Performance.? In (ed.), Performing Psychology: A Postmodern Culture of the Mind. New York: Routledge, 1999, pp. 49-69.", "volume-title": "Performing Psychology: A Postmodern Culture of the Mind"}, {"key": "BIB6", "author": "Holzman", "volume": "17", "first-page": "86", "year": "2000", "journal-title": "Educational and Child Psychology"}, {"key": "BIB7", "author": "Moll", "year": "1990", "unstructured": "(ed.). Vygotsky and Education: Instructional Implications and Applications of Socio-Historical Psychology. New York: Cambridge University Press, 1990.", "volume-title": "Vygotsky and Education: Instructional Implications and Applications of Socio-Historical Psychology", "DOI": "10.1017/CBO9781139173674", "doi-asserted-by": "crossref"}, {"key": "BIB8", "author": "Newman", "year": "1993", "unstructured": "and Lev Vygotsky: Revolutionary Scientist. London: Routledge, 1993.", "volume-title": "Lev Vygotsky: Revolutionary Scientist"}, {"key": "BIB9", "author": "Newman", "year": "1996", "unstructured": "and Unscientific Psychology: A Cultural-Performatory Approach to Understanding Human Life. Westport, Conn.: Praeger, 1996.", "volume-title": "Unscientific Psychology: A Cultural-Performatory Approach to Understanding Human Life"}, {"key": "BIB10", "author": "Newman", "year": "1997", "unstructured": "and The End of Knowing: A New Developmental Way of Learning. London: Routledge, 1997.", "volume-title": "The End of Knowing: A New Developmental Way of Learning"}, {"key": "BIB11", "author": "Sabo", "year": "1999", "unstructured": "?Young People's Involvement in Evaluating the Programs That Serve Them.? Unpublished doctoral dissertation, City University of New York Graduate School, 1999."}, {"key": "BIB12", "author": "Vygotsky", "year": "1978", "unstructured": "Mind in Society. Cambridge, Mass.: Harvard University Press, 1978.", "volume-title": "Mind in Society"}, {"key": "BIB13", "author": "Vygotsky", "volume": "1", "year": "1987", "unstructured": "The Collected Works of L. S. Vygotsky. Vol. 1. New York: Plenum, 1987.", "series-title": "The Collected"}, {"key": "BIB14", "author": "Wells", "year": "1999", "unstructured": "Dialogic Inquiry: Toward a Sociocultural Practice and Theory of Education. Cambridge, U.K.: Cambridge University Press, 1999.", "volume-title": "Dialogic Inquiry: Toward a Sociocultural Practice and Theory of Education", "DOI": "10.1017/CBO9780511605895", "doi-asserted-by": "crossref"}, {"key": "BIB15", "author": "Wertsch", "year": "1985", "unstructured": "Vygotsky and the Social Formation of Mind. Cambridge, Mass.: Harvard University Press, 1985.", "volume-title": "Vygotsky and the Social Formation of Mind"}, {"key": "BIB16", "author": "Wertsch", "year": "1991", "unstructured": "Voices of the Mind: A Sociocultural Approach to Meditated Action. Cambridge, Mass.: Harvard University Press, 1991.", "volume-title": "Voices of the Mind: A Sociocultural Approach to Meditated Action"}], "container-title": ["New Directions for Evaluation"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fev.81", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://onlinelibrary.wiley.com/doi/full/10.1002/ev.81", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 8, 1]], "date-time": "2018-08-01T03:58:01Z", "timestamp": 1533095881000}, "score": 19.174782, "issued": {"date-parts": [[2003]]}, "references-count": 16, "journal-issue": {"published-print": {"date-parts": [[2003]]}, "issue": "98"}, "URL": "http://dx.doi.org/10.1002/ev.81", "relation": {"cites": []}, "ISSN": ["1097-6736", "1534-875X"], "issn-type": [{"value": "1097-6736", "type": "print"}, {"value": "1534-875X", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T12:41:57Z", "timestamp": 1574167317568}, "reference-count": 40, "publisher": "Wiley", "issue": "98", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 4626, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["New Directions for Evaluation"], "published-print": {"date-parts": [[2003]]}, "DOI": "10.1002/ev.80", "type": "journal-article", "created": {"date-parts": [[2003, 7, 1]], "date-time": "2003-07-01T10:02:39Z", "timestamp": 1057053759000}, "page": "1-11", "source": "Crossref", "is-referenced-by-count": 7, "title": ["Editor's Notes"], "prefix": "10.1002", "volume": "2003", "author": [{"given": "Kim", "family": "Sabo", "sequence": "first", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2003, 6, 30]]}, "reference": [{"key": "BIB1", "author": "Andrews", "volume": "18", "first-page": "478", "year": "1995", "journal-title": "Education and Treatment of Children"}, {"key": "BIB2", "author": "Botvin", "volume": "273", "first-page": "1106", "year": "1995", "journal-title": "Journal of the American Medical Association", "DOI": "10.1001/jama.1995.03520380042033", "doi-asserted-by": "crossref"}, {"key": "BIB3", "series-title": "New Direction", "volume-title": "Understanding and Practicing Participatory Evaluation", "volume": "80", "author": "Brisolara", "year": "1998", "unstructured": "?The History of Participatory Evaluation and Current Debates in the Field.? In and (eds.), Understanding and Practicing Participatory Evaluation. New Directions for Evaluation, no. 80. San Francisco: Jossey-Bass, 1998."}, {"key": "BIB4", "author": "Camino", "year": "1992", "unstructured": "What Differences Do Racial, Ethnic, and Cultural Differences Make in Youth Development Programs? Washington, D.C.: Carnegie Council on Adolescent Development, 1992.", "volume-title": "What Differences Do Racial, Ethnic, and Cultural Differences Make in Youth Development Programs?"}, {"key": "BIB5", "author": "Camino", "volume": "15", "first-page": "10", "year": "1999", "journal-title": "New Designs for Youth Development"}, {"key": "BIB6", "author": "Carr", "year": "1986", "unstructured": "and Becoming Critical: Education, Knowledge, and Action Research. London: Falmer Press, 1986.", "volume-title": "Becoming Critical: Education, Knowledge, and Action Research"}, {"key": "BIB7", "author": "Chawla", "year": "2001", "unstructured": "?Evaluating Children's Participation: Seeking Areas of Consensus.? PLA [Participatory Learning and Action] Notes: Children's Participation: Evaluating Effectiveness. London: International Institute for Environment and Development, 2001.", "volume-title": "PLA [Participatory Learning and Action] Notes: Children's Participation: Evaluating Effectiveness"}, {"key": "BIB8", "author": "Checkoway", "year": "1992", "unstructured": "and Young People as Community Builders. Ann Arbor: School of Social Work, University of Michigan, 1992.", "volume-title": "Young People as Community Builders"}, {"key": "BIB9", "author": "Choudhary", "year": "1988", "unstructured": "and Participatory Evaluation. New Delhi, India: Society for Participatory Research in Asia, 1988.", "volume-title": "Participatory Evaluation"}, {"key": "BIB10", "author": "Collier", "volume": "12", "first-page": "265", "year": "1945", "journal-title": "Social Research"}, {"key": "BIB11", "author": "Corey", "volume": "9", "first-page": "478", "year": "1952", "journal-title": "Educational Leadership"}, {"key": "BIB12", "author": "Corey", "year": "1953", "unstructured": "Action Research to Improve School Practices. New York: Teachers College, Columbia University, 1953.", "volume-title": "Action Research to Improve School Practices"}, {"key": "BIB13", "author": "Cousins", "year": "1995", "unstructured": "and ?Collaborative Evaluation: Survey of Practice in North America.? Paper presented at the joint meeting of the Canadian Evaluation Society and the American Evaluation Association, Vancouver, B.C., Nov. 1995."}, {"key": "BIB14", "series-title": "New Direction", "volume-title": "Understanding and Practicing Participatory Evaluation", "volume": "80", "author": "Cousins", "year": "1998", "unstructured": "and ?Framing Participatory Evaluation.? In and (eds.), Understanding and Practicing Participatory Evaluation. New Directions for Evaluation, no. 80. San Francisco: Jossey-Bass, 1998."}, {"key": "BIB15", "author": "Deegan", "year": "1988", "unstructured": "A People's History of the United States. New York: Harper & Row, 1988.", "volume-title": "A People's History of the United States"}, {"key": "BIB16", "series-title": "The Later Wor", "first-page": "14", "volume": "5", "author": "Dewey", "year": "1984", "unstructured": "?The Sources of a Science of Education.? In (ed.), The Later Works. Vol. 5. Carbondale: Southern Illinois University Press, 1984, pp. 14-15. (Originally published 1929.)"}, {"key": "BIB17", "author": "Hart", "year": "1997", "unstructured": "Children's Participation: The Theory and Practice of Involving Young Citizens in Community Development and Environmental Care. London and New York: Earthscan and UNICEF, 1997.", "volume-title": "Children's Participation: The Theory and Practice of Involving Young Citizens in Community Development and Environmental Care"}, {"key": "BIB18", "author": "Hawkins", "volume": "153", "first-page": "226", "year": "1999", "journal-title": "Archives of Pediatrics and Adolescent Medicine", "DOI": "10.1001/archpedi.153.3.226", "doi-asserted-by": "crossref"}, {"key": "BIB19", "author": "James", "volume": "8", "first-page": "1", "year": "2001", "journal-title": "Nonprofit Quarterly"}, {"key": "BIB20", "author": "Kusche", "year": "1994", "unstructured": "and Teaching PATHS in Your Classroom: The PATHS (Promoting Alternative Thinking Strategies) Curriculum Instruction Manual. Seattle: Developmental Research Programs, 1994.", "volume-title": "Teaching PATHS in Your Classroom: The PATHS (Promoting Alternative Thinking Strategies) Curriculum Instruction Manual"}, {"key": "BIB21", "author": "Lewin", "year": "1948", "unstructured": "Resolving Social Conflicts. New York: Harper & Row, 1948.", "volume-title": "Resolving Social Conflicts"}, {"key": "BIB22", "author": "Lewin", "first-page": "449", "year": "1952", "unstructured": "?Group Decision and Social Change.? In and (eds.), Reading in Social Psychology. New York: Henry Holt, 1952, 449-473.", "volume-title": "Reading in Social Psychology"}, {"key": "BIB23", "author": "Meucci", "volume": "24", "first-page": "1", "year": "1997", "journal-title": "Social Justice"}, {"key": "BIB24", "author": "National Collaboration for Youth", "year": "1996", "unstructured": "National Collaboration for Youth. Position Statement on Accountability and Evaluation in Youth Development Organizations. Washington, D.C.: National Collaboration for Youth, 1996.", "volume-title": "Position Statement on Accountability and Evaluation in Youth Development Organizations"}, {"key": "BIB25", "author": "Nisbet", "year": "1980", "unstructured": "and The Impact of Research on Policy and Practice in Education. Aberdeen, Texas: Aberdeen University Press, 1980.", "volume-title": "The Impact of Research on Policy and Practice in Education"}, {"key": "BIB26", "author": "Oja", "year": "1989", "unstructured": "and Collaborative Action Research: A Developmental Approach. London: Falmer Press, 1989.", "volume-title": "Collaborative Action Research: A Developmental Approach"}, {"key": "BIB27", "author": "Papineau", "volume": "27", "first-page": "56", "year": "1994", "journal-title": "Community Psychologist"}, {"key": "BIB28", "author": "Pittman", "year": "1991", "unstructured": "and A New Vision: Promoting Youth Development. Commissioned Paper no. 3. Washington, D.C.: Academy for Educational Development, Center for Youth Development and Policy Research, 1991.", "volume-title": "A New Vision: Promoting Youth Development"}, {"key": "BIB29", "author": "Pittman", "year": "1991", "unstructured": "and Bridging the Gap: A Rationale for Enhancing the Role of Community Organizations in Promoting Youth Development. Washington, D.C.: Academy for Educational Development, 1991.", "volume-title": "Bridging the Gap: A Rationale for Enhancing the Role of Community Organizations in Promoting Youth Development"}, {"key": "BIB30", "author": "Reason", "year": "1988", "unstructured": "Human Inquiry in Action: Developments in New Paradigm Research. Newbury Park, Calif.: Sage, 1988.", "volume-title": "Human Inquiry in Action: Developments in New Paradigm Research"}, {"key": "BIB31", "author": "Sabo", "year": "2001", "unstructured": "?The Benefits of Participatory Evaluation for Children and Youth.? PLA Notes. London: International Institute for Environment and Development, 2001.", "volume-title": "PLA Notes"}, {"key": "BIB32", "author": "Shapiro", "volume": "10", "first-page": "191", "year": "1988", "journal-title": "Educational Evaluation and Policy Analysis"}, {"key": "BIB33", "author": "Shulha", "year": "1995", "unstructured": "and ?Utilization and Social Justice: Interconnections of Meta-Evaluation Frameworks.? Paper presented at the joint meeting of the Canadian Evaluation Society and the American Evaluation Association, Vancouver, B.C., Nov. 1995."}, {"key": "BIB34", "author": "Slavin", "volume": "1", "first-page": "41", "year": "1996", "journal-title": "Journal of Education for Students Placed at Risk", "DOI": "10.1207/s15327671espr0101_6", "doi-asserted-by": "crossref"}, {"key": "BIB35", "author": "Smith", "volume": "62", "first-page": "83", "year": "1992", "journal-title": "Journal of School Health", "DOI": "10.1111/j.1746-1561.1992.tb06022.x", "doi-asserted-by": "crossref"}, {"key": "BIB36", "author": "Stull", "year": "1987", "unstructured": "and Collaborative Research and Social Change: Applied Anthropology in Action. Boulder, Colo.: Westview Press, 1987.", "volume-title": "Collaborative Research and Social Change: Applied Anthropology in Action"}, {"key": "BIB37", "author": "Tierney", "year": "1995", "unstructured": "and Making a Difference: An Impact Study of Big Brothers/Big Sisters. Philadelphia: Public/Private Ventures, 1995.", "volume-title": "Making a Difference: An Impact Study of Big Brothers/Big Sisters"}, {"key": "BIB38", "author": "Whitmore", "volume": "7", "first-page": "215", "year": "1990", "journal-title": "Canadian Social Work Review"}, {"key": "BIB39", "author": "Whyte", "year": "1990", "unstructured": "(ed.). Participatory Action Research. Newbury Park, Calif.: Sage, 1990.", "volume-title": "Participatory Action Research"}, {"key": "BIB40", "year": "2002", "unstructured": "Youth Participation in Community Research and Evaluation. Symposium Proceedings. Wingspread, Wisc., 2002."}], "container-title": ["New Directions for Evaluation"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fev.80", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://onlinelibrary.wiley.com/doi/full/10.1002/ev.80", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 8, 4]], "date-time": "2018-08-04T02:23:30Z", "timestamp": 1533349410000}, "score": 19.174782, "issued": {"date-parts": [[2003]]}, "references-count": 40, "journal-issue": {"published-print": {"date-parts": [[2003]]}, "issue": "98"}, "URL": "http://dx.doi.org/10.1002/ev.80", "relation": {"cites": []}, "ISSN": ["1097-6736", "1534-875X"], "issn-type": [{"value": "1097-6736", "type": "print"}, {"value": "1534-875X", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T18:27:58Z", "timestamp": 1574792878683}, "reference-count": 1, "publisher": "Wiley", "issue": "35", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 11690, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Chemischer Informationsdienst"], "published-print": {"date-parts": [[1983, 8, 30]]}, "DOI": "10.1002/chin.198335238", "type": "journal-article", "created": {"date-parts": [[2016, 5, 4]], "date-time": "2016-05-04T19:13:14Z", "timestamp": 1462389194000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["ChemInform Abstract: ANTIMYCOTIC AZOLES. 6. SYNTHESIS AND ANTIFUNGAL PROPERTIES OF TERCONAZOLE, A NOVEL TRIAZOLE KETAL"], "prefix": "10.1002", "volume": "14", "author": [{"given": "J.", "family": "HEERES", "sequence": "first", "affiliation": []}, {"given": "R.", "family": "HENDRICKX", "sequence": "additional", "affiliation": []}, {"given": "J.", "family": "VAN CUTSEM", "sequence": "additional", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2016, 5, 4]]}, "reference": [{"key": "10.1002/chin.198335238-BIB1|cit1", "doi-asserted-by": "crossref", "first-page": "611", "DOI": "10.1021/jm00358a032", "article-title": "ANTIMYCOTIC AZOLES. 6. SYNTHESIS AND ANTIFUNGAL PROPERTIES OF TERCONAZOLE, A NOVEL TRIAZOLE KETAL", "volume": "26", "author": "HEERES", "year": "1983", "journal-title": "J. Med. Chem."}], "container-title": ["Chemischer Informationsdienst"], "language": "en", "link": [{"URL": "http://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fchin.198335238", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fchin.198335238", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://onlinelibrary.wiley.com/doi/full/10.1002/chin.198335238", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 8, 6]], "date-time": "2018-08-06T16:49:01Z", "timestamp": 1533574141000}, "score": 18.86493, "issued": {"date-parts": [[1983, 8, 30]]}, "references-count": 1, "journal-issue": {"published-print": {"date-parts": [[1983, 8, 30]]}, "issue": "35"}, "URL": "http://dx.doi.org/10.1002/chin.198335238", "archive": ["Portico"], "relation": {"cites": []}, "ISSN": ["0009-2975"], "issn-type": [{"value": "0009-2975", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 30]], "date-time": "2019-11-30T17:42:18Z", "timestamp": 1575135738521}, "reference-count": 0, "publisher": "American Chemical Society (ACS)", "issue": "4", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["J. Med. Chem."], "published-print": {"date-parts": [[1983, 4]]}, "DOI": "10.1021/jm00358a032", "type": "journal-article", "created": {"date-parts": [[2005, 3, 18]], "date-time": "2005-03-18T10:33:08Z", "timestamp": 1111141988000}, "page": "611-613", "source": "Crossref", "is-referenced-by-count": 33, "title": ["Antimycotic azoles. 6. Synthesis and antifungal properties of terconazole, a novel triazole ketal"], "prefix": "10.1021", "volume": "26", "author": [{"given": "J.", "family": "Heeres", "sequence": "first", "affiliation": []}, {"given": "R.", "family": "Hendrickx", "sequence": "additional", "affiliation": []}, {"given": "J.", "family": "Van Cutsem", "sequence": "additional", "affiliation": []}], "member": "316", "container-title": ["Journal of Medicinal Chemistry"], "language": "en", "link": [{"URL": "https://pubs.acs.org/doi/pdf/10.1021/jm00358a032", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 9, 29]], "date-time": "2019-09-29T11:00:04Z", "timestamp": 1569754804000}, "score": 18.86493, "issued": {"date-parts": [[1983, 4]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1983, 4]]}, "issue": "4"}, "alternative-id": ["10.1021/jm00358a032"], "URL": "http://dx.doi.org/10.1021/jm00358a032", "ISSN": ["0022-2623", "1520-4804"], "issn-type": [{"value": "0022-2623", "type": "print"}, {"value": "1520-4804", "type": "electronic"}], "subject": ["Molecular Medicine", "Drug Discovery"]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T15:54:25Z", "timestamp": 1574178865308}, "reference-count": 23, "publisher": "Springer Science and Business Media LLC", "issue": "1", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2006, 1, 19]], "date-time": "2006-01-19T00:00:00Z", "timestamp": 1137628800000}, "delay-in-days": 0, "content-version": "unspecified"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Trials"], "published-print": {"date-parts": [[2006, 12]]}, "DOI": "10.1186/1745-6215-7-3", "type": "journal-article", "created": {"date-parts": [[2006, 1, 23]], "date-time": "2006-01-23T12:44:43Z", "timestamp": 1138020283000}, "source": "Crossref", "is-referenced-by-count": 9, "title": ["Flaws in design, analysis and interpretation of Pfizer's antifungal trials of voriconazole and uncritical subsequent quotations"], "prefix": "10.1186", "volume": "7", "author": [{"given": "Karsten J", "family": "J\u00f8rgensen", "sequence": "first", "affiliation": []}, {"given": "Helle Krogh", "family": "Johansen", "sequence": "additional", "affiliation": []}, {"given": "Peter C", "family": "G\u00f8tzsche", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2006, 1, 19]]}, "reference": [{"key": "140_CR1", "author": "PC G\u00f8tzsche", "year": "2002", "unstructured": "G\u00f8tzsche PC, Johansen HK: Routine versus selective antifungal administration for control of fungal infections in patients with cancer. The Cochrane Database of Systematic Reviews. 2002, Art. No.: CD000026, 2", "volume-title": "Routine versus selective antifungal administration for control of fungal infections in patients with cancer", "DOI": "10.1002/14651858.CD000026", "doi-asserted-by": "publisher"}, {"key": "140_CR2", "author": "HK Johansen", "year": "2000", "unstructured": "Johansen HK, G\u00f8tzsche PC: Amphotericin B lipid soluble formulations versus amphotericin B in cancer patients with neutropenia. The Cochrane Database of Systematic Reviews. 2000, Art.No.: CD000969, 3", "volume-title": "Amphotericin B lipid soluble formulations versus amphotericin B in cancer patients with neutropenia", "DOI": "10.1002/14651858.CD000969", "doi-asserted-by": "publisher"}, {"key": "140_CR3", "doi-asserted-by": "publisher", "first-page": "1752", "DOI": "10.1001/jama.282.18.1752", "volume": "282", "author": "HK Johansen", "year": "1999", "unstructured": "Johansen HK, G\u00f8tzsche PC: Problems in the design and reporting of trials of antifungal agents encountered during meta-analysis. JAMA. 1999, 282: 1752-9. 10.1001/jama.282.18.1752.", "journal-title": "JAMA"}, {"key": "140_CR4", "author": "KJ J\u00f8rgensen", "year": "2006", "unstructured": "J\u00f8rgensen KJ, Johansen HK, G\u00f8tzsche PC: Voriconazole versus amphotericin B in cancer patients with neutropenia. The Cochrane Database of Systematic Reviews. 2006, Art. No.: CD004707, 1", "volume-title": "Voriconazole versus amphotericin B in cancer patients with neutropenia", "DOI": "10.1002/14651858.CD004707.pub2", "doi-asserted-by": "publisher"}, {"key": "140_CR5", "doi-asserted-by": "publisher", "first-page": "225", "DOI": "10.1056/NEJM200201243460403", "volume": "346", "author": "TJ Walsh", "year": "2002", "unstructured": "Walsh TJ, Pappas P, Winston DJ, Lazarus HM, Petersen F, Raffalli J, Yanovich S, Stiff P, Greenberg R, Donowitz G, Schuster M, Reboli A, Wingard J, Arndt C, Reinhardt J, Hadley S, Finberg R, Laverdiere M, Perfect J, Garber G, Fioritoni G, Anaissie E, Lee J, National Institute of Allergy and Infectious Diseases Mycoses Study Group: Voriconazole compared with liposomal amphothericin B for empirical antifungal therapy in patients with neutropenia and persistent fever. N Engl J Med. 2002, 346: 225-234. 10.1056/NEJM200201243460403.", "journal-title": "N Engl J Med"}, {"key": "140_CR6", "doi-asserted-by": "publisher", "first-page": "408", "DOI": "10.1056/NEJMoa020191", "volume": "347", "author": "R Herbrecht", "year": "2002", "unstructured": "Herbrecht R, Denning DW, Patterson TF, Bennett JE, Greene RE, Oestmann JW, Kern WV, Marr KA, Ribaud P, Lortholary O, Sylvester R, Rubin RH, Wingard JR, Stark P, Durand C, Caillot D, Thiel E, Chandrasekar PH, Hodges MR, Schlamm HT, Troke PF, de Pauw B, Invasive Fungal Infections Group of the European Organisation for Research and Treatment of Cancer and the Global Aspergillus Study Group: Voriconazole versus amphothericin B for primary therapy of invasive aspergillosis. N Engl J Med. 2002, 347: 408-415. 10.1056/NEJMoa020191.", "journal-title": "N Engl J Med"}, {"key": "140_CR7", "doi-asserted-by": "publisher", "first-page": "289", "DOI": "10.1056/NEJM200201243460414", "volume": "346", "author": "JH Powers", "year": "2002", "unstructured": "Powers JH, Dixon CA, Goldberger MJ: Voriconazole versus liposomal amphotericin B in patients with neutropenia and persistent fever. N Engl J Med. 2002, 346: 289-290. 10.1056/NEJM200201243460414.", "journal-title": "N Engl J Med"}, {"key": "140_CR8", "author": "HK Johansen", "year": "2002", "unstructured": "Johansen HK, G\u00f8tzsche PC: Amphotericin B versus fluconazole for controlling fungal infections in neutropenic cancer patients. The Cochrane Database of Systematic Reviews. 2002, Art. No.: CD000239, 2", "volume-title": "Amphotericin B versus fluconazole for controlling fungal infections in neutropenic cancer patients", "DOI": "10.1002/14651858.CD000239", "doi-asserted-by": "publisher"}, {"key": "140_CR9", "doi-asserted-by": "publisher", "first-page": "1391", "DOI": "10.1056/NEJMoa040446", "volume": "351", "author": "TJ Walsh", "year": "2004", "unstructured": "Walsh TJ, Teppler H, Donowitz GR, Maertens JA, Baden LR, Dmoszynska A, Cornely OA, Bourque MR, Lupinacci RJ, Sable CA, dePauw BE: Caspofungin versus liposomal amphothericin B for empirical antifungal therapy in patients with persistent fever and neutropenia. N Engl J Med. 2004, 351: 1391-402. 10.1056/NEJMoa040446.", "journal-title": "N Engl J Med"}, {"key": "140_CR10", "doi-asserted-by": "publisher", "first-page": "51", "DOI": "10.1007/s005200050224", "volume": "7", "author": "J Mayer", "year": "1999", "unstructured": "Mayer J, Doubek M, Vorlicek J: Must we really fear toxicity of conventional amphotericin B in oncological patients?. Support Care Cancer. 1999, 7: 51-5. 10.1007/s005200050224.", "journal-title": "Support Care Cancer"}, {"key": "140_CR11", "doi-asserted-by": "crossref", "first-page": "1417", "DOI": "10.1128/AAC.43.6.1417", "volume": "43", "author": "CE Nath", "year": "1999", "unstructured": "Nath CE, Shaw PJ, Gunning R, McLachlan AJ, Earl JW: Amphotericin B in children with malignant disease: a comparison of the toxicities and pharmacokinetics of amphotericin B administered in dextrose versus lipid emulsion. Antimicrobial Agents and Chemotherapy. 1999, 43: 1417-23.", "journal-title": "Antimicrobial Agents and Chemotherapy"}, {"key": "140_CR12", "unstructured": "ISI Web of Science. [ http://isiknowledge.com/ ]"}, {"key": "140_CR13", "doi-asserted-by": "publisher", "first-page": "2", "DOI": "10.1111/j.1469-0691.2004.00809.x", "volume": "10", "author": "WW Hope", "year": "2004", "unstructured": "Hope WW, Denning DW: Invasive aspergillosis: current and future challenges in diagnosis and therapy. Clin Microbiol Infect. 2004, 10: 2-4. 10.1111/j.1469-0691.2004.00809.x.", "journal-title": "Clin Microbiol Infect"}, {"issue": "5", "key": "140_CR14", "doi-asserted-by": "publisher", "first-page": "e138", "DOI": "10.1371/journal.pmed.0020138", "volume": "2", "author": "R Smith", "year": "2005", "unstructured": "Smith R: Medical journals are an extension of the marketing arm of pharmaceutical companies. PLoS Med. 2005, 2 (5): e138-10.1371/journal.pmed.0020138.", "journal-title": "PLoS Med"}, {"key": "140_CR15", "doi-asserted-by": "publisher", "first-page": "22", "DOI": "10.1192/bjp.183.1.22", "volume": "183", "author": "D Healy", "year": "2003", "unstructured": "Healy D, Cattell D: Interface between authorship, industry and science in the domain of therapeutics. Br J Psychiatry. 2003, 183: 22-7. 10.1192/bjp.183.1.22.", "journal-title": "Br J Psychiatry"}, {"key": "140_CR16", "doi-asserted-by": "publisher", "first-page": "1901", "DOI": "10.1056/NEJMe020074", "volume": "346", "author": "JM Drazen", "year": "2002", "unstructured": "Drazen JM, Curfman GD: Financial associations of authors. N Engl J Med. 2002, 346: 1901-2. 10.1056/NEJMe020074.", "journal-title": "N Engl J Med"}, {"key": "140_CR17", "first-page": "334", "volume": "54", "author": "LM Schmidt", "year": "2005", "unstructured": "Schmidt LM, G\u00f8tzsche PC: Of mites and men: reference bias in narrative review articles: a systematic review. J Fam Pract. 2005, 54: 334-8.", "journal-title": "J Fam Pract"}, {"key": "140_CR18", "doi-asserted-by": "publisher", "first-page": "15", "DOI": "10.1136/bmj.305.6844.15", "volume": "305", "author": "U Ravnskov", "year": "1992", "unstructured": "Ravnskov U: Cholesterol lowering trials in coronary heart disease: frequency of citation and outcome. BMJ. 1992, 305: 15-9.", "journal-title": "BMJ"}, {"key": "140_CR19", "doi-asserted-by": "publisher", "first-page": "713", "DOI": "10.1016/0895-4356(94)00222-C", "volume": "48", "author": "U Ravnskov", "year": "1995", "unstructured": "Ravnskov U: Quotation bias in reviews of the diet-heart idea. J Clin Epidemiol. 1995, 48: 713-9. 10.1016/0895-4356(94)00222-C.", "journal-title": "J Clin Epidemiol"}, {"key": "140_CR20", "doi-asserted-by": "publisher", "first-page": "654", "DOI": "10.1136/bmj.295.6599.654", "volume": "295", "author": "PC G\u00f8tzsche", "year": "1987", "unstructured": "G\u00f8tzsche PC: Reference bias in reports of drug trials. BMJ. 1987, 295: 654-6.", "journal-title": "BMJ"}, {"key": "140_CR21", "doi-asserted-by": "publisher", "first-page": "921", "DOI": "10.1001/jama.290.7.921", "volume": "290", "author": "B Als-Nielsen", "year": "2003", "unstructured": "Als-Nielsen B, Chen W, Gluud C, Kjaergard LL: Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events?. JAMA. 2003, 290: 921-8. 10.1001/jama.290.7.921.", "journal-title": "JAMA"}, {"key": "140_CR22", "author": "PC G\u00f8tzsche", "year": "2006", "unstructured": "G\u00f8tzsche PC: Are relative risks and odds ratios in abstracts believable? Cross-sectional study. BMJ. 2006,", "volume-title": "BMJ"}, {"issue": "5", "key": "140_CR23", "doi-asserted-by": "publisher", "first-page": "e126", "DOI": "10.1371/journal.pmed.0020126", "volume": "2", "author": "DG Altman", "year": "2005", "unstructured": "Altman DG: Unjustified restrictions on letter to the editor. PLoS Med. 2005, 2 (5): e126-10.1371/journal.pmed.0020126.", "journal-title": "PLoS Med"}], "container-title": ["Trials"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1186/1745-6215-7-3.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/article/10.1186/1745-6215-7-3/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1186/1745-6215-7-3", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 4, 15]], "date-time": "2019-04-15T23:01:15Z", "timestamp": 1555369275000}, "score": 18.863255, "issued": {"date-parts": [[2006, 1, 19]]}, "references-count": 23, "journal-issue": {"published-print": {"date-parts": [[2006, 12]]}, "issue": "1"}, "alternative-id": ["140"], "URL": "http://dx.doi.org/10.1186/1745-6215-7-3", "relation": {"cites": []}, "ISSN": ["1745-6215"], "issn-type": [{"value": "1745-6215", "type": "electronic"}], "article-number": "3"}, {"indexed": {"date-parts": [[2019, 11, 25]], "date-time": "2019-11-25T16:43:22Z", "timestamp": 1574700202665}, "reference-count": 0, "publisher": "Informa UK Limited", "issue": "4", "content-domain": {"domain": ["www.tandfonline.com"], "crossmark-restriction": true}, "short-container-title": ["Medical Reference Services Quarterly"], "published-print": {"date-parts": [[2016, 10]]}, "DOI": "10.1080/02763869.2016.1220767", "type": "journal-article", "created": {"date-parts": [[2016, 9, 22]], "date-time": "2016-09-22T20:57:15Z", "timestamp": 1474577835000}, "page": "469-470", "update-policy": "http://dx.doi.org/10.1080/tandf_crossmark_01", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Repositioning Reference: New Methods and New Services for a New Age,by Laura Saunders, Lillian Rozaklis, and Eileen G. Abels"], "prefix": "10.1080", "volume": "35", "author": [{"given": "Robin", "family": "Sabo", "sequence": "first", "affiliation": []}], "member": "301", "published-online": {"date-parts": [[2016, 9, 22]]}, "container-title": ["Medical Reference Services Quarterly"], "language": "en", "link": [{"URL": "http://www.tandfonline.com/doi/pdf/10.1080/02763869.2016.1220767", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 15]], "date-time": "2016-12-15T19:13:10Z", "timestamp": 1481829190000}, "score": 18.732529, "subtitle": ["Lanham, MD: Rowman & Littlefield, 2015. 157p. ISBN 978-0-8108-9211-8. $45.00 (softcover)."], "issued": {"date-parts": [[2016, 9, 22]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2016, 9, 22]]}, "published-print": {"date-parts": [[2016, 10]]}, "issue": "4"}, "alternative-id": ["10.1080/02763869.2016.1220767"], "URL": "http://dx.doi.org/10.1080/02763869.2016.1220767", "ISSN": ["0276-3869", "1540-9597"], "issn-type": [{"value": "0276-3869", "type": "print"}, {"value": "1540-9597", "type": "electronic"}], "assertion": [{"value": "The publishing and review policy for this title is described in its Aims & Scope.", "order": 1, "name": "peerreview_statement", "label": "Peer Review Statement"}, {"value": "http://www.tandfonline.com/action/journalInformation?show=aimsScope&journalCode=wmrs20", "URL": "http://www.tandfonline.com/action/journalInformation?show=aimsScope&journalCode=wmrs20", "order": 2, "name": "aims_and_scope_url", "label": "Aim & Scope"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T13:52:36Z", "timestamp": 1574517156048}, "reference-count": 20, "publisher": "Wiley", "issue": "3", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 1014, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2013, 5]]}, "DOI": "10.1111/myc.12023", "type": "journal-article", "created": {"date-parts": [[2012, 11, 21]], "date-time": "2012-11-21T16:18:09Z", "timestamp": 1353514689000}, "page": "304-310", "source": "Crossref", "is-referenced-by-count": 36, "title": ["Posaconazole after previous antifungal therapy with voriconazole for therapy of invasive aspergillus disease, a retrospective analysis"], "prefix": "10.1111", "volume": "56", "author": [{"given": "Werner J.", "family": "Heinz", "sequence": "first", "affiliation": []}, {"given": "Gerlinde", "family": "Egerer", "sequence": "additional", "affiliation": []}, {"given": "Heinrich", "family": "Lellek", "sequence": "additional", "affiliation": []}, {"given": "Angelika", "family": "Boehme", "sequence": "additional", "affiliation": []}, {"given": "Jochen", "family": "Greiner", "sequence": "additional", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2012, 11, 21]]}, "reference": [{"key": "10.1111/myc.12023-BIB1|cit1", "doi-asserted-by": "crossref", "first-page": "197", "DOI": "10.1111/j.1439-0507.2009.01691.x", "article-title": "The changing face of epidemiology of invasive fungal disease in Europe", "volume": "52", "author": "Lass-Fl\u00f6rl", "year": "2009", "journal-title": "Mycoses"}, {"key": "10.1111/myc.12023-BIB2|cit2", "doi-asserted-by": "crossref", "first-page": "1091", "DOI": "10.1086/651263", "article-title": "Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database", "volume": "50", "author": "Kontoyiannis", "year": "2010", "journal-title": "Clin Infect Dis"}, {"key": "10.1111/myc.12023-BIB3|cit3", "first-page": "110", "article-title": "Posaconazole: when and how? The clinician\u2019s view", "volume": "55", "author": "Katragkou", "year": "2012", "journal-title": "Mycoses"}, {"key": "10.1111/myc.12023-BIB4|cit4", "first-page": "175", "article-title": "Epidemiology and treatment approaches in management of invasive fungal infections", "volume": "3", "author": "Kriengkauykiat", "year": "2011", "journal-title": "Clin Epidemiol"}, {"key": "10.1111/myc.12023-BIB5|cit5", "doi-asserted-by": "crossref", "first-page": "1279", "DOI": "10.1517/13543780903176407", "article-title": "New generation azole antifungals in clinical investigation", "volume": "18", "author": "Girmenia", "year": "2009", "journal-title": "Expert Opin Investig Drugs"}, {"key": "10.1111/myc.12023-BIB6|cit6", "unstructured": "EMA Noxafil: EPAR - product information 2011"}, {"key": "10.1111/myc.12023-BIB7|cit7", "unstructured": "DGHO Deutsche Gesellschaft f\u00fcr H\u00e4matologie und Onkologie e.V Invasive Pilzinfektionen-Therapie Leitlinie 2009"}, {"key": "10.1111/myc.12023-BIB8|cit8", "doi-asserted-by": "crossref", "first-page": "709", "DOI": "10.1038/bmt.2010.175", "article-title": "European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3-2009 Update", "volume": "46", "author": "Maertens", "year": "2011", "journal-title": "Bone Marrow Transplant"}, {"key": "10.1111/myc.12023-BIB9|cit9", "doi-asserted-by": "crossref", "first-page": "327", "DOI": "10.1086/525258", "article-title": "Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America", "volume": "46", "author": "Walsh", "year": "2008", "journal-title": "Clin Infect Dis"}, {"key": "10.1111/myc.12023-BIB10|cit10", "doi-asserted-by": "crossref", "first-page": "2", "DOI": "10.1086/508774", "article-title": "Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial", "volume": "44", "author": "Walsh", "year": "2007", "journal-title": "Clin Infect Dis"}, {"key": "10.1111/myc.12023-BIB11|cit11", "doi-asserted-by": "crossref", "first-page": "e219", "DOI": "10.1371/journal.pmed.0050219", "article-title": "Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism", "volume": "5", "author": "Snelders", "year": "2008", "journal-title": "PLoS Med"}, {"key": "10.1111/myc.12023-BIB12|cit12", "doi-asserted-by": "crossref", "first-page": "1813", "DOI": "10.1086/588660", "article-title": "Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group", "volume": "46", "author": "De Pauw", "year": "2008", "journal-title": "Clin Infect Dis"}, {"key": "10.1111/myc.12023-BIB13|cit13", "doi-asserted-by": "crossref", "first-page": "337", "DOI": "10.1016/j.jinf.2006.03.003", "article-title": "Micafungin (FK463), alone or in combination with other systemic antifungal agents, for the treatment of acute invasive aspergillosis", "volume": "53", "author": "Denning", "year": "2006", "journal-title": "J Infect"}, {"key": "10.1111/myc.12023-BIB14|cit14", "doi-asserted-by": "crossref", "first-page": "1386", "DOI": "10.1093/jac/dkn401", "article-title": "Posaconazole as salvage treatment of invasive fungal infections in patients with underlying renal impairment", "volume": "62", "author": "Hachem", "year": "2008", "journal-title": "J Antimicrob Chemother"}, {"key": "10.1111/myc.12023-BIB15|cit15", "doi-asserted-by": "crossref", "first-page": "e449", "DOI": "10.1111/j.1439-0507.2010.01947.x", "article-title": "Efficacy outcomes in a randomised trial of liposomal amphotericin B based on revised EORTC/MSG 2008 definitions of invasive mould disease", "volume": "54", "author": "Cornely", "year": "2011", "journal-title": "Mycoses"}, {"key": "10.1111/myc.12023-BIB16|cit16", "doi-asserted-by": "crossref", "first-page": "89", "DOI": "10.1111/j.1399-3062.2007.00208.x", "article-title": "Posaconazole salvage therapy allows successful allogeneic hematopoietic stem cell transplantation in patients with refractory invasive mold infections", "volume": "9", "author": "Mullane", "year": "2007", "journal-title": "Transpl Infect Dis"}, {"key": "10.1111/myc.12023-BIB17|cit17", "doi-asserted-by": "crossref", "first-page": "1684", "DOI": "10.1086/430068", "article-title": "Posaconazole as salvage therapy in patients with chronic granulomatous disease and invasive filamentous fungal infection", "volume": "40", "author": "Segal", "year": "2005", "journal-title": "Clin Infect Dis"}, {"key": "10.1111/myc.12023-BIB18|cit18", "doi-asserted-by": "crossref", "first-page": "563", "DOI": "10.1086/324620", "article-title": "Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis", "volume": "34", "author": "Denning", "year": "2002", "journal-title": "Clin Infect Dis"}, {"key": "10.1111/myc.12023-BIB19|cit19", "doi-asserted-by": "crossref", "first-page": "408", "DOI": "10.1056/NEJMoa020191", "article-title": "Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis", "volume": "347", "author": "Herbrecht", "year": "2002", "journal-title": "N Engl J Med"}, {"key": "10.1111/myc.12023-BIB20|cit20", "doi-asserted-by": "crossref", "first-page": "527 e17", "DOI": "10.1016/j.amjmed.2005.11.028", "article-title": "Voriconazole treatment for subacute invasive and chronic pulmonary aspergillosis", "volume": "119", "author": "Sambatakou", "year": "2006", "journal-title": "Am J Med"}], "container-title": ["Mycoses"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fmyc.12023", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2017, 6, 21]], "date-time": "2017-06-21T02:58:44Z", "timestamp": 1498013924000}, "score": 18.707808, "subtitle": ["Posaconazole after voriconazole in aspergillosis"], "issued": {"date-parts": [[2012, 11, 21]]}, "references-count": 20, "journal-issue": {"published-print": {"date-parts": [[2013, 5]]}, "issue": "3"}, "URL": "http://dx.doi.org/10.1111/myc.12023", "relation": {"cites": []}, "ISSN": ["0933-7407"], "issn-type": [{"value": "0933-7407", "type": "print"}]}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}